[go: up one dir, main page]

WO2018021022A1 - Cell treatment device - Google Patents

Cell treatment device Download PDF

Info

Publication number
WO2018021022A1
WO2018021022A1 PCT/JP2017/025323 JP2017025323W WO2018021022A1 WO 2018021022 A1 WO2018021022 A1 WO 2018021022A1 JP 2017025323 W JP2017025323 W JP 2017025323W WO 2018021022 A1 WO2018021022 A1 WO 2018021022A1
Authority
WO
WIPO (PCT)
Prior art keywords
cell
flow path
flow
unit
storage container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2017/025323
Other languages
French (fr)
Japanese (ja)
Inventor
淳史 稲田
英俊 高山
英章 香川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Corp
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of WO2018021022A1 publication Critical patent/WO2018021022A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/02Tissue, human, animal or plant cell, or virus culture apparatus with means providing suspensions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/06Tissue, human, animal or plant cell, or virus culture apparatus with filtration, ultrafiltration, inverse osmosis or dialysis means

Definitions

  • the technology of the present disclosure relates to a cell processing apparatus.
  • Japanese Patent Application Laid-Open No. 2010-011792 discloses a culture apparatus, a separation apparatus having filter means connected to the culture tank, and a liquid medium connected to the separation apparatus and stored in the surface of the filter means of the separation apparatus.
  • the culture apparatus provided with the culture-medium transfer tank supplied in the direction parallel to is described. This culture apparatus can reciprocate a liquid medium between a medium transfer tank and a culture tank.
  • Japanese Patent Application Laid-Open No. 01-206988 discloses a culture system in which a culture medium containing cells or the like is circulated or stored to proliferate cells, and the liquid medium in the culture system can be continuously replaced with a fresh medium.
  • a culture apparatus with a liquid-replenishment / separation means is described.
  • This culturing apparatus is provided with a bypass channel that can temporarily bypass the culture solution to the outside of the culture system.
  • the bypass channel allows the cells in the culture solution to permeate but the cell mass or the like.
  • a cell lump removing unit made of a cylindrical body with a built-in filter.
  • the following configuration can be considered as a configuration of a cell processing apparatus that automates a series of cell culture processes including the above-described division processing, medium replacement processing, and concentration processing.
  • annular circulation flow path or the branched flow path branched from the circulation flow path can be considered.
  • an annular circulation channel is shared in each process, and it is considered that there is a high risk of so-called contamination in which cells before and after the division process are mixed.
  • some cells attached to the wall surface of the circulation channel while the cell suspension is being transferred through the circulation channel are not subjected to the division process, and these cells are not transmitted through the circulation channel.
  • cultured cells used for regenerative medicine need to guarantee the homogeneity of cells in the same lot, it is important to reduce the risk of contamination in which cells before and after the division process are mixed.
  • the technology of the present disclosure provides a cell processing apparatus that can reduce the risk of contamination in which cells before and after division processing are mixed.
  • a first aspect of the present disclosure is a cell processing apparatus, a cell supply unit that supplies cells, and a downstream side of the cell supply unit, and is connected to the cell supply unit via a first flow path, A concentration unit that performs a concentration process for removing the liquid from the cell suspension containing the cells and the liquid accompanying the cell, and is connected to the concentration unit via the second channel provided downstream of the concentration unit, A dividing unit that performs a dividing process of dividing the aggregate.
  • the first flow path is a one-way flow path in which the cell suspension passing through the first flow path flows from the upstream side toward the downstream side.
  • the second channel is a one-way channel in which the cell suspension passing through the second channel flows from the upstream side toward the downstream side.
  • the concentrating unit has one flow port connected to the first flow channel, the other flow port connected to the second flow channel, Concentrate the cell suspension flowing from the flow port or the other flow port, and concentrate from one of the flow ports and the other flow port that is different from the flow port into which the cell suspension flows.
  • a filter unit for discharging the treated cell suspension may be included.
  • the dividing unit may include a discharge port for discharging the cells subjected to the dividing process.
  • the fourth aspect of the present disclosure may include a third flow path connected to the discharge port and a cell recovery container connected to the third flow path.
  • the fifth aspect of the present disclosure may include the first bypass flow path having one end connected to the second flow path and the other end connected to the third flow path in the fourth aspect. Good.
  • the concentration unit includes a first storage container connected to the first flow path, and a second storage container connected to the second flow path. And may be included.
  • the first storage container causes the cell suspension to flow in and out via the first circulation port connected to the first flow path.
  • the second storage container preferably allows the cell suspension to flow in and out through the second flow port connected to the second flow path.
  • the first circulation port is provided at a bottom portion of the first storage container, and the second circulation port is a bottom portion of the second storage container. Is preferably provided.
  • the first pressure control unit that controls the pressure inside the first storage container and the pressure inside the second storage container are controlled. And a second pressure control unit.
  • the stirring unit may include a static mixer.
  • the second bypass flow having one end connected to the first flow path and the other end connected to the second flow path. It may contain roads.
  • the concentration unit may include a plurality of filter units arranged in series or in parallel with each other between the first channel and the second channel. Good.
  • the filter unit may perform filtration using a tangential flow method, or may perform separation using centrifugal force.
  • the concentration unit when the concentration unit includes a plurality of filter units, uses a first filter unit that performs filtration by a tangential flow method and a centrifugal force. And a second filter unit that performs the separation.
  • the seventeenth aspect of the present disclosure may include a first medium supply unit connected to the first flow path in the above aspect.
  • the eighteenth aspect of the present disclosure may include a second culture medium supply unit connected to the third flow path in the fourth and fifth aspects.
  • the nineteenth aspect of the present disclosure may include a cleaning liquid supply unit that supplies a cleaning liquid to the cell supply unit in the above aspect.
  • FIG. 1 It is a figure which shows the structure of the cell processing apparatus which concerns on exemplary embodiment of this invention. It is a figure which shows an example of the aspect of filtration in the filter part which concerns on exemplary embodiment of this invention. It is a figure which shows an example of the usage condition of the cell processing apparatus which concerns on exemplary embodiment of this invention. It is a figure which shows the flow of a cell, a culture medium, etc. in case the cell processing apparatus which concerns on exemplary embodiment of this invention performs a division
  • FIG. 1 is a diagram showing a configuration of a cell processing apparatus 1 according to a first exemplary embodiment of the present invention.
  • the cell processing apparatus 1 includes a cell supply unit 10, a concentration unit 20, and a division unit 30 as main components.
  • the cell treatment apparatus 1 further includes medium supply units 51 and 52, a cleaning liquid supply unit 60, and a stirring unit 40.
  • the cell supply unit 10 supplies cells to be processed by the cell processing apparatus 1.
  • the cell supply part 10 is comprised including the storage container which accommodates a cell.
  • the cell supply unit 10 discharges cells from the circulation port 10a provided at the bottom.
  • the circulation port 10a is connected to the first flow path F1 through the valve V1.
  • the valve V1 is opened when the cells accommodated in the cell supply unit 10 are allowed to flow out to the first flow path F1, and is closed otherwise.
  • the concentration unit 20 is provided on the downstream side of the cell supply unit 10 and is connected to the cell supply unit 10 via the first flow path F1.
  • the concentration unit 20 removes debris such as dead cells that have separated from the liquid and cell aggregates into a single cell from a cell suspension containing cells and a liquid (for example, a medium) associated with the cell, thereby suspending the cell suspension. Concentration treatment is performed to increase the concentration of cells contained in the solution.
  • the concentrating unit 20 includes a filter unit 21, a filtrate recovery container 22, and two storage containers 23A and 23B.
  • the filter unit 21 has a flow port 21a connected to the first flow path F1 via the valve V2, and a flow port 21b connected to the second flow path F2 via the valve V3.
  • the filter unit 21 performs a concentration process on the cell suspension flowing from the flow port 21a or 21b, and performs a concentration process from a flow port different from the flow port into which the cell suspension flows. Is discharged. For example, the cell suspension that has flowed into the filter unit 21 from the flow port 21a is concentrated in the filter unit 21, and the cell suspension that has been subjected to the concentration process is discharged from the flow port 21b.
  • the filter unit 21 constitutes, for example, a filtration device that performs filtration by a tangential flow (cross flow) method, and the cell suspension flows along the membrane surface of the filtration membrane disposed inside the filtration device. It is configured as follows.
  • FIG. 2 is a diagram illustrating an example of a filtration mode in the filter unit 21.
  • the filter part 21 has the filtration membrane M which consists of hollow fibers, for example.
  • the filtration membrane M may be a porous membrane, and the material of the filtration membrane M may be a metal, a polymer, a ceramic sintered body, or the like.
  • the filter unit 21 may perform filtration by a dead end flow method in which the cell suspension flow direction intersects the membrane surface of the filtration membrane.
  • the filter unit 21 may perform separation using centrifugal force.
  • Valves V2 and V3 are open when the concentration process is performed in the filter unit 21, and are closed otherwise.
  • the storage containers 23 ⁇ / b> A and 23 ⁇ / b> B are containers for temporarily storing a cell suspension that is a target of each process performed in the cell processing apparatus 1.
  • the form of the storage containers 23A and 23B is not particularly limited, and for example, a glass or stainless steel container or a container having a plastic bag form can be used.
  • the storage container 23A has a flow port 23a provided at the bottom thereof, and the cell suspension flows in or out through the flow port 23a. That is, the distribution port 23a serves both as an inlet and an outlet of the storage container 23A.
  • the circulation port 23a is connected to the first flow path F1 through the valve V4.
  • the valve V4 is opened when the cell suspension is allowed to flow into the storage container 23A or when the cell suspension is allowed to flow out of the storage container 23A, and is otherwise closed.
  • the storage container 23B has a flow port 23b provided at the bottom thereof, and the cell suspension flows in or out through the flow port 23b. That is, the circulation port 23b serves both as an inlet and an outlet of the storage container 23B.
  • the circulation port 23b is connected to the second flow path F2 through the valve V5.
  • the valve V5 is opened when the cell suspension is caused to flow into the storage container 23B or when the cell suspension is caused to flow out of the storage container 23B, and is otherwise closed.
  • the storage container 23A is provided with a pressurizing device 24A and a pressure control device 25A.
  • the pressurizing device 24A has a function of pressurizing the inside of the storage container 23A.
  • the pressure control device 25A controls the pressure at which the pressurizing device 24A pressurizes the inside of the storage container 23A.
  • a pressurizing device 24B and a pressure control device 25B are provided in the storage container 23B.
  • the pressurizing device 24B has a function of pressurizing the inside of the storage container 23B.
  • the pressure control device 25B controls the pressure at which the pressurizing device 24B pressurizes the inside of the storage container 23B.
  • the cell suspension can be transferred between the storage container 23A and the storage container 23B by pressure control by the pressure control devices 25A and 25B. For example, by making the pressure inside the storage container 23A higher than the pressure inside the storage container 23B, the cell suspension stored in the storage container 23A can be transferred to the storage container 23B. Further, by making the pressure inside the storage container 23B higher than the pressure inside the storage container 23A, the cell suspension stored in the storage container 23B can be transferred to the storage container 23A.
  • the case where the cell suspension is transferred by causing a pressure difference in the storage containers 23A and 23B by the pressurizing means that pressurizes the pressure inside the storage containers 23A and 23B is illustrated. It is not limited to the embodiment.
  • the cell suspension may be transferred by generating a pressure difference in the storage containers 23A and 23B by a decompression unit that reduces the pressure inside the storage containers 23A and 23B. Further, the cell suspension may be transferred by generating a pressure difference in the storage containers 23A and 23B by a combination of the pressurizing means and the decompressing means.
  • the cell suspension passes through the filter unit 21, thereby performing a plurality of concentration processes by the filter unit 21. It becomes possible to carry out continuously over time. Therefore, the concentration of the cell suspension can be adjusted by the number of reciprocating movements of the cell suspension between the storage container 23A and the storage container 23B.
  • the stirring unit 40 has a function of stirring the flowing cell suspension.
  • One end of the stirring unit 40 is connected to the first flow path F1 through the valve V9, and the other end of the stirring unit 40 is connected to the second flow path F2 through the valve V10. Yes.
  • the agitation unit 40 performs the agitation process on the cell suspension flowing from one end or the other end, and performs the agitation process from an end different from the end into which the cell suspension has flowed. Drain the suspension.
  • the stirrer 40 preferably has a configuration as a so-called static mixer that does not have a drive unit.
  • the agitator 40 is fixedly installed inside the tubular body and inside the tubular body, and has a spiral flow path inside the tubular body. And a stirring element that forms the structure.
  • the flow path inside the tubular body constituting the static mixer does not necessarily need to be spiral.
  • the static mixer may have a structure in which the inner diameter of the tubular body is changed so that the fluid passing through the inside of the tubular body can be stirred.
  • Valves V9 and V10 are opened when stirring is performed in the stirring section 40, and are closed otherwise.
  • the cell treatment device 1 has a bypass channel F20 between the first channel F1 and the second channel F2. That is, one end of the bypass flow path F20 is connected to the first flow path F1 via the valve V11, and the other end of the bypass flow path F20 is connected to the second flow path F2 via the valve V12. ing.
  • Valves V11 and V12 are opened when the cell suspension is passed through the bypass flow path F20, and are closed otherwise.
  • the filter unit 21, the stirring unit 40, and the bypass channel F20 are arranged in parallel between the first channel F1 and the second channel F2. Can be selectively used. That is, the cell suspension supplied through the first flow path F1 passes through the filter section 21, the stirring section 40, and the bypass flow path F20 before being transferred to the second flow path F2. Is also possible.
  • the dividing unit 30 has a function of performing a dividing process of dividing a cell aggregate formed by culturing cells.
  • the dividing process performed in the dividing unit 30 may be a mechanical dividing process or an enzyme process using a cell dissociating enzyme.
  • the dividing unit 30 includes a processing container and a mesh filter provided inside the processing container. By passing the cell suspension containing the cell aggregate through the mesh filter, the cell aggregate is divided into sizes according to the mesh size of the mesh filter.
  • a porous plate or a through-hole plate can be used as a means for dividing the cell aggregate.
  • the division unit 30 includes a treatment container in which a cell dissociation enzyme such as trypsin-EDTA (ethylenediaminetetraacetic acid) is accommodated.
  • a cell dissociation enzyme such as trypsin-EDTA (ethylenediaminetetraacetic acid) is accommodated.
  • Cell aggregates are divided by immersing the cell aggregates in a cell dissociation enzyme for a certain period of time
  • the dividing unit 30 has an inlet 30a connected to the second flow path F2 via the valve V13 and an outlet 30b connected to the third flow path F3 via the valve V14.
  • the dividing unit 30 performs a dividing process on the cell aggregate included in the cell suspension flowing in from the inflow port 30a, and discharges the cell suspension including the cell aggregate subjected to the dividing process from the outflow port 30b. To do.
  • Valves V13 and V14 are opened when the dividing unit 30 performs division processing, and are otherwise closed.
  • the cell treatment device 1 has a bypass channel F10 between the second channel F2 and the third channel F3. That is, one end of the bypass flow path F10 is connected to the second flow path F2 via the valve V15, and the other end of the bypass flow path F10 is connected to the third flow path F3 via the valve V16. ing.
  • Valves V15 and V16 are opened when the cell suspension is passed through the bypass flow path F10, and are closed otherwise.
  • the cell treatment apparatus 1 has two medium supply parts 51 and 52.
  • the culture medium supply unit 51 includes a storage container that stores a fresh culture medium.
  • the culture medium supply part 51 discharges
  • the discharge port 51a is connected to the first flow path F1 through the valve V17.
  • the valve V ⁇ b> 17 is opened when the medium stored in the medium supply unit 51 flows out to the first flow path F ⁇ b> 1, and is closed otherwise.
  • the discharge port 51a can be disposed at a position other than the bottom of the medium supply unit 51.
  • the medium supply unit 52 discharges the medium from the discharge port 52a provided at the bottom.
  • the discharge port 52a is connected to the third flow path F3 through the valve V18.
  • the valve V18 is opened when the medium accommodated in the medium supply unit 52 is caused to flow out to the third flow path F3, and is closed otherwise.
  • the discharge port 52a can be disposed at a position other than the bottom of the medium supply unit 52.
  • the cleaning liquid supply unit 60 includes a storage container that stores a cleaning liquid for cleaning the cell supply unit 10 and the filter unit 21.
  • the cleaning liquid supply unit 60 is connected to the cell supply unit 10 via the valve V19.
  • the valve V19 is opened when cleaning with the cleaning liquid stored in the cleaning liquid supply unit 60, and is closed otherwise. By opening the valve V19, the cleaning liquid stored in the cleaning liquid supply unit 60 flows into the cell supply unit 10, and the inside of the container constituting the cell supply unit 10 is cleaned. As a result, the cells remaining in the cell supply unit 10 can be scraped and collected by the flow of the washing liquid.
  • the cell collection container 100 is a container for collecting the cell suspension processed by the cell processing apparatus 1.
  • the form of the cell collection container 100 is not particularly limited, and for example, a glass or stainless steel container or a container having a plastic bag form can be used.
  • the cell collection container 100 has a flow port 100a provided at the bottom thereof, and the cell suspension processed by the cell processing apparatus 1 flows through the flow port 100a.
  • the flow port 100a of the cell collection container 100 is connected to the third flow path F3 via the valve V22.
  • the valve V22 is opened when the treated cell suspension is allowed to flow into the cell collection container 100, and is closed otherwise.
  • the cell collection container 100 is connected to the cell supply unit 10 as shown in FIG.
  • the valve V22 is opened when the cell suspension accommodated in the cell collection container 100 is allowed to flow into the cell supply unit 10, and is closed otherwise.
  • connection part X between the pipes constituting each flow path is constituted by a sterilization connector.
  • the flow direction of the cell suspension passing through the first flow path F1 is controlled so as to always be the direction from the cell supply unit 10 toward the concentration unit 20 (the direction of the arrow shown in FIG. 1). It is preferred that
  • the liquid flow of the cell suspension passing through the first channel F1 may be formed by, for example, a pump (not shown) disposed on the first channel F1. In this case, it is possible to control the flow direction of the cell suspension passing through the first flow path F1 by the rotation direction of the pump arranged on the first flow path F1.
  • the liquid flow of the cell suspension passing through the first flow path F1 is formed by a differential pressure between the pressure inside the cell supply unit 10 or the medium supply unit 51 and the pressure inside the storage container 23A or 23B. May be.
  • the same mechanism as the pressurization devices 24A and 24B and the pressure control devices 25A and 25B provided in the storage containers 23A and 23B is provided in the cell supply unit 10 and the culture medium supply unit 51.
  • the pressure inside the cell supply unit 10 higher than the pressure inside the storage container 23A or 23B, the flow direction of the cell suspension passing through the first flow path F1 is changed to the cell supply unit 10.
  • the direction toward the concentrating unit 20 can be made.
  • the means for forming the liquid flow of the cell suspension passing through the first flow path F1 is not limited to the application of pressure to the inside of the cell supply unit 10, the medium supply unit 51, and the storage containers 23A and 23B. Pressure may be applied from the outside.
  • a valve V20 may be provided at the downstream end of the first flow path F1 in order to prevent the back flow of the cell suspension in the first flow path F1.
  • the valve V20 is opened when the cell suspension is passed through the first flow path F1, and is closed otherwise.
  • a check valve, a check valve or the like can be used as another means for preventing the back flow of the cell suspension in the first flow path F1.
  • the flow direction of the cell suspension passing through the second flow path F2 is always the direction from the concentration unit 20, the stirring unit 40, or the bypass flow channel F20 toward the dividing unit 30 or the bypass flow channel F10 ( It is preferably controlled so that the direction of the arrow shown in FIG.
  • the liquid flow of the cell suspension passing through the second flow path F2 may be formed by, for example, a pump (not shown) disposed on the second flow path F2. In this case, it is possible to control the flow direction of the cell suspension passing through the second flow path F2 by the rotation direction of the pump disposed on the second flow path F2.
  • the liquid flow of the cell suspension passing through the second flow path F2 may be formed by a differential pressure between the pressure inside the storage container 23A or 23B and the pressure inside the cell collection container 100. Or you may form by the differential pressure
  • the cell recovery container 100 or the dividing unit 30 is provided with the same mechanism as the pressurization devices 24A and 24B and the pressure control devices 25A and 25B provided in the storage containers 23A and 23B.
  • the flow direction of the cell suspension passing through the second flow path F2 is changed to the concentration unit. 20, It can be set as the direction which goes to the division
  • a valve V21 may be provided at the upstream end of the second flow path F2.
  • the valve V21 is opened when the cell suspension is passed through the second flow path F2, and is closed otherwise.
  • a check valve or a check valve can be used as another means for preventing the back flow of the cell suspension in the second flow path F2.
  • the flow direction of the cell suspension passing through the third flow path F3 is always the direction from the dividing section 30 or the bypass flow path F10 toward the cell collection container 100 (indicated by the arrow shown in FIG. 1). Direction).
  • the liquid flow of the cell suspension passing through the third flow path F3 may be formed by, for example, a pump (not shown) arranged on the third flow path F3. In this case, it is possible to control the flow direction of the cell suspension passing through the third flow path F3 by the rotation direction of the pump disposed on the third flow path F3.
  • the liquid flow of the cell suspension passing through the third flow path F3 may be formed by a differential pressure between the pressure inside the storage container 23A or 23B and the pressure inside the cell collection container 100.
  • the cell recovery container 100 is provided with the same mechanism as the pressurization devices 24A and 24B and the pressure control devices 25A and 25B provided in the storage containers 23A and 23B.
  • the flow direction of the cell suspension passing through the third flow path F3 is changed to the dividing unit 30 or the bypass.
  • the direction can be the direction from the flow path F10 toward the cell collection container 100.
  • the control unit 70 performs opening / closing control of the valves V1 to V21.
  • the control unit 70 The operation control of each pump is performed in conjunction with the opening / closing operation of the valves V1 to V21.
  • the pressure adjustment mechanism provided in each of these units Is controlled in conjunction with the opening and closing operations of the valves V1 to V21.
  • control unit 70 performs liquid feeding control so that the cell suspension flows through a predetermined path in each process performed in the cell processing apparatus 1.
  • control of the opening and closing of the valve V22 associated with the cell collection container 100 may be performed by the control unit 70 or manually.
  • the cell treatment apparatus 1 can perform, for example, a division process, a medium exchange process, and a concentration process exemplified below.
  • FIG. 4 is a diagram illustrating a flow of cells, a medium, and the like when the cell processing apparatus 1 performs a division process.
  • FIG. 4 shows the correspondence between the flow of cells and culture medium, etc., and the following processing steps.
  • the cell aggregates to be subjected to the division process are accommodated in the cell supply unit 10 and supplied from the cell supply unit 10.
  • step S1 the valves V1, V20, V11, V12, and V5 are opened, and are accommodated in the cell supply unit 10 by controlling the operation of the pump or controlling the differential pressure between the cell supply unit 10 and the storage container 23B.
  • the cell suspension is transferred to the storage container 23B via the first flow path F1 and the bypass flow path F20.
  • step S2 the valve V19 is opened.
  • the cleaning liquid stored in the cleaning liquid supply unit 60 flows into the cell supply unit 10 and the cell supply unit 10 is cleaned. Thereby, the cells (cell aggregates) remaining in the cell supply unit 10 are scraped off by the flow of the cleaning liquid.
  • step S3 the valves V1, V20, V11, V12 and V5 are opened and remain in the cell supply unit 10 by controlling the operation of the pump or controlling the differential pressure between the cell supply unit 10 and the storage container 23B.
  • the cells (cell aggregates) and the washing liquid are transferred to the storage container 23B via the first flow path F1 and the bypass flow path F20. That is, the cells (cell aggregates) remaining in the cell supply unit 10 are stored in the storage container 23B together with the cells (cell aggregates) transferred to the storage container 23B in step S1.
  • step S4 the valves V5, V3, V2, and V4 are opened, and the cells (cell aggregates) stored in the storage container 23B, the washing liquid, and the control are performed by controlling the differential pressure between the storage container 23A and the storage container 23B.
  • the cell suspension containing the medium is transferred to the storage container 23A via the filter unit 21.
  • the cell suspension is concentrated while passing through the filter unit 21.
  • the filter unit 21 performs a concentration process for removing the washing solution and the medium from the cell suspension containing the cells (cell aggregates), the washing solution and the medium flowing in from the flow port 21b to increase the concentration of the cells.
  • the washing liquid and the culture medium are collected in the filtrate collection container 22, and the concentrated cell suspension is discharged from the circulation port 21a and stored in the storage container 23A.
  • step S5 the valves V19, V1, V20, V11, V12, and V5 are opened and accommodated in the cleaning liquid supply unit 60 by controlling the operation of the pump or controlling the differential pressure between the cell supply unit 10 and the storage container 23B.
  • the washed liquid thus transferred is transferred to the storage container 23B via the cell supply unit 10, the first flow path F1, and the bypass flow path F20.
  • the valves V5, V3, V2, and V4 are opened, and the cleaning liquid stored in the storage container 23B flows to the filter unit 21 by the differential pressure control between the storage container 23A and the storage container 23B.
  • step S6 the valves V17, V20, and V4 are opened, and the fresh medium stored in the medium supply unit 51 is controlled by the pump operation control or the differential pressure control between the medium supply unit 51 and the storage container 23A. It is transferred to the storage container 23A via the first flow path F1. Thereby, a fresh culture medium is supplied to the cells (cell aggregates) stored in the storage container 23A.
  • step S7 the valves V4, V9, V10, V21, V13, V14, and V22 are opened and stored in the storage container 23A by pump operation control or differential pressure control between the storage container 23A and the cell collection container 100.
  • the cell suspension thus obtained is transferred to the cell collection container 100 via the stirring unit 40, the second channel F2, the dividing unit 30, and the third channel F3.
  • the cell suspension is stirred by passing through the stirring unit 40. Thereby, cells (cell aggregates) are uniformly dispersed in the medium.
  • the cell suspension that has passed through the stirring unit 40 flows into the processing container of the dividing unit 30 from the inflow port 30a.
  • the cells (cell aggregates) contained in the suspension flow into the processing container of the dividing unit 30 and pass through the mesh filter provided in the processing container, thereby being divided into sizes according to the mesh size of the mesh filter. .
  • the cell suspension containing the cells (cell aggregates) subjected to the division treatment is discharged from the outflow port 30b and is stored in the cell collection container 100 via the third flow path F3.
  • step S8 the valves V18 and V22 are opened, and the fresh medium stored in the medium supply unit 52 is controlled by the pump operation control or the differential pressure control between the medium supply unit 52 and the cell collection container 100. It is transferred to the cell collection container 100 via the third flow path F3. Thereby, the quantity of the culture medium in the cell collection container 100 is adjusted. If adjustment of the amount of medium is not required, the medium supply from the medium supply unit 52 may be omitted.
  • the cells collected in the cell collection container 100 are transferred to a cell culture container (not shown), and the cell culture is continued. Further, all or a part of the cell suspension containing the cells (cell aggregates) subjected to the dividing process by the dividing unit 30 may be stored in a storage container and stored frozen.
  • FIG. 5 is a diagram illustrating a flow of cells, a medium, and the like when the cell processing apparatus 1 performs a medium replacement process.
  • FIG. 5 shows the correspondence between the flow of cells and culture medium, etc., and the following processing steps.
  • the cell collection container 100 When replacing a used medium stored in the cell collection container 100 with a fresh medium, the cell collection container 100 is connected to the cell supply unit 10 as shown in FIG. Thereafter, by opening the valve V22, the cell suspension containing the used medium contained in the cell collection container 100 is put into the cell supply unit 10. Thereafter, the cell collection container 100 is connected to the third flow path F3 as shown in FIG.
  • step S11 the valves V1, V20, V11, V12, and V5 are opened, and are accommodated in the cell supply unit 10 by pump operation control or differential pressure control between the cell supply unit 10 and the storage container 23B.
  • the cell suspension containing the used medium is transferred to the storage container 23B via the first channel F1 and the bypass channel F20.
  • step S12 the valve V19 is opened.
  • the cleaning liquid stored in the cleaning liquid supply unit 60 flows into the cell supply unit 10 and the cell supply unit 10 is cleaned. Thereby, the cells remaining in the cell supply unit 10 are scraped off by the flow of the cleaning liquid.
  • step S13 the valves V1, V20, V11, V12, and V5 are opened and remain in the cell supply unit 10 by controlling the operation of the pump or controlling the differential pressure between the cell supply unit 10 and the storage container 23B.
  • the cells and the washing liquid are transferred to the storage container 23B via the first flow path F1 and the bypass flow path F20. That is, the cells remaining in the cell supply unit 10 are stored in the storage container 23B together with the cells transferred to the storage container 23B in step S11.
  • step S14 the valves V5, V3, V2, and V4 are opened, and the cells stored in the storage container 23B, the washing solution, and the used medium are included by controlling the differential pressure between the storage container 23A and the storage container 23B.
  • the cell suspension is transferred to the storage container 23A via the filter unit 21.
  • the cell suspension is concentrated while passing through the filter unit 21.
  • the filter unit 21 performs a concentration process to remove the washing solution and the used medium from the cell suspension containing the cells, the washing solution, and the used medium that have flowed from the flow port 21b, thereby increasing the cell concentration.
  • the washing liquid and the used culture medium are collected in the filtrate collection container 22, and the concentrated cell suspension is discharged from the circulation port 21a and stored in the storage container 23A.
  • step S15 the valves V1, V20, V11, V12, and V5 are opened, and are accommodated in the cleaning liquid supply unit 60 by pump operation control or differential pressure control between the cell supply unit 10 and the storage container 23B.
  • the cleaning solution is transferred to the storage container 23B via the cell supply unit 10, the first flow path F1, and the bypass flow path F20.
  • the valves V5, V3, V2, and V4 are opened, and the cleaning liquid stored in the storage container 23B flows to the filter unit 21 by the differential pressure control between the storage container 23A and the storage container 23B.
  • the cleaning liquid flows through the filter unit 21, the cells remaining on the filtration membrane of the filter unit 21 are scraped off by the liquid flow of the cleaning liquid and stored in the storage container 23A together with the cells transferred to the storage container 23A in step S14. .
  • step S16 the valves V17, V20, and V4 are opened, and the fresh medium stored in the medium supply unit 51 by controlling the operation of the pump or controlling the differential pressure between the medium supply unit 51 and the storage container 23A. Is transferred to the storage container 23A via the first flow path F1. Thereby, a fresh culture medium is supplied to the cells stored in the storage container 23A.
  • step S17 the valves V4, V9, V10, V21, V15, V16, and V22 are opened, and stored in the storage container 23A by pump operation control or differential pressure control between the storage container 23A and the cell collection container 100.
  • the cell suspension thus obtained is transferred to the cell collection container 100 via the stirring unit 40, the second flow path F2, the bypass flow path F10, and the third flow path F3.
  • the cell suspension is stirred by passing through the stirring unit 40. Thereby, the cells are uniformly dispersed in the medium.
  • the cell suspension that has passed through the stirring unit 40 is accommodated in the cell collection container 100 via the second flow path F2, the bypass flow path F10, and the third flow path F3.
  • step S18 the valves V18 and V22 are opened, and the fresh medium contained in the medium supply unit 52 is controlled by controlling the operation of the pump or controlling the differential pressure between the medium supply unit 52 and the cell collection container 100. 3 is transferred to the cell collection container 100 via the flow path F3. Thereby, the quantity of the culture medium in the cell collection container 100 is adjusted. If adjustment of the amount of medium is not required, the medium supply from the medium supply unit 52 may be omitted.
  • FIG. 6 is a diagram illustrating the flow of cells, culture medium, and the like when the cell processing apparatus 1 performs the concentration process alone.
  • FIG. 6 shows the correspondence between the flow of cells and culture medium and the following processing steps.
  • the cell collection container 100 When the cell suspension in the cell collection container 100 is concentrated, the cell collection container 100 is connected to the cell supply unit 10 as shown in FIG. Thereafter, by opening the valve V22, the cell suspension containing the cells and the medium contained in the cell collection container 100 is put into the cell supply unit 10. Thereafter, the cell collection container 100 is connected to the third flow path F3 as shown in FIG. In addition, it is also possible to perform a concentration process for objects other than the cell suspension in the cell collection container 100.
  • step S31 the valves V1, V20, and V4 are opened, and the cell suspension accommodated in the cell supply unit 10 is controlled by pump operation control or differential pressure control between the cell supply unit 10 and the storage container 23A. Then, it is transferred to the storage container 23A via the first flow path F1.
  • step S32 the valve V19 is opened.
  • the cleaning liquid stored in the cleaning liquid supply unit 60 flows into the cell supply unit 10 and the cell supply unit 10 is cleaned. Thereby, the cells remaining in the cell supply unit 10 are scraped off by the flow of the cleaning liquid.
  • step S33 the valves V1, V20 and V4 are opened, and the cells and washing liquid remaining in the cell supply unit 10 by controlling the operation of the pump or controlling the differential pressure between the cell supply unit 10 and the storage container 23A. Is transferred to the storage container 23A via the first flow path F1. That is, the cells remaining in the cell supply unit 10 are stored in the storage container 23A together with the cells transferred to the storage container 23A in step S31.
  • step S34 the valves V4, V2, V3, V21, V15, V16, and V22 are opened and stored in the storage container 23A by pump operation control or differential pressure control between the storage container 23A and the cell collection container 100.
  • the cell suspension containing the cells, the washing solution, and the culture medium is transferred into the cell collection container 100 via the filter unit 21, the second channel F2, the bypass channel F10, and the third channel F3. .
  • the cell suspension is concentrated while passing through the filter unit 21.
  • the filter unit 21 removes debris such as dead cells that have been detached from the washing solution, the medium, and the cell aggregate from the cell suspension containing the cells, the washing solution, and the medium that have flowed in from the flow port 21a, thereby forming a single cell concentration. To increase the concentration.
  • the washing liquid, the medium, and the debris are collected in the filtrate collection container 22, and the concentrated cell suspension is discharged from the circulation port 21b, and the second flow path F2, the bypass flow path F10, and the third flow path F3.
  • step S35 the valves V19, V1, V20, V2, V3, V21, V15, V16, and V22 are opened, and pump pressure control or differential pressure control between the cell supply unit 10 and the cell collection container 100 is performed.
  • the cleaning liquid stored in the cleaning liquid supply unit 60 is recovered through the cell supply unit 10, the first channel F1, the filter unit 21, the second channel F2, the bypass channel F10, and the third channel F3. It is transferred to the container 100.
  • the washing liquid flows into the filter unit 21 cells remaining on the filtration membrane of the filter unit 21 are scraped off by the washing liquid flow, and are accommodated in the cell collection container 100 together with the cells contained in the cell collection container 100 in step S34. Is done.
  • step S36 the valves V18 and V22 are opened, and the fresh medium contained in the medium supply unit 52 is controlled by the pump operation control or the differential pressure control between the medium supply unit 52 and the cell collection container 100. 3 is transferred to the cell collection container 100 via the flow path F3. Thereby, the quantity of the culture medium in the cell collection container 100 is adjusted. If adjustment of the amount of medium is not required, the medium supply from the medium supply unit 52 may be omitted.
  • the concentration unit 20 is provided on the downstream side of the cell supply unit 10, and the cells are passed through the first flow path F1. It is connected to the supply unit 10.
  • the dividing unit 30 is provided on the downstream side of the concentration unit 20 and is connected to the concentration unit 20 via the second flow path F2. That is, in the cell treatment apparatus 1, the cell supply unit 10, the concentration unit 20, and the division unit 30 are configured to be connected in series in this order. As shown in FIG. 1, when the cell collection container 100 is connected to the third flow path F3, the cell supply unit 10, the concentration unit 20, the dividing unit 30, and the cell collection container 100 are connected in series in this order. It becomes the composition which was done.
  • the flow direction of the cell suspension passing through the first flow path F1, the second flow path F2, and the third flow path F3 is only one direction. That is, the first flow path F1, the second flow path F2, and the third flow path F3 are one-way flow paths.
  • the bypass flow path F10 is blocked, and only the cells that have passed through the division unit 30 are collected in the cell collection container 100.
  • the cells are not collected in the cell collection container 100 without passing through the division unit 30. Therefore, it is possible to prevent the occurrence of contamination in which the cells before the division process and the cells after the division process are mixed.
  • the cell processing apparatus 1 which concerns on exemplary embodiment of this invention, before the cell supplied from the cell supply part 10 is collect
  • the dividing unit 30 and the bypass channel F10 are arranged in parallel between the second channel F2 and the third channel F3. . Thereby, when performing culture medium exchange processing or concentration processing, the processed cell suspension can be collected in the cell collection container 100 without going through the dividing unit 30.
  • the filter unit 21, the stirring unit 40, and the bypass channel F20 are arranged in parallel between the first channel F1 and the second channel F2.
  • the cell treatment device 1 includes a storage container 23A connected to the first flow path F1 and a storage container 23B connected to the second flow path F2, and between the storage container 23A and the storage container 23B.
  • the filter part 21, the stirring part 40, and the bypass flow path F20 can be used as a bidirectional
  • the concentration process in the filter unit 21 and the stirring process in the stirring unit 40 can be continuously performed. Furthermore, the mutual transfer of the cell suspension between the storage container 23A and the storage container 23B can be performed via the bypass channel F20, and the cell suspension supplied from the cell supply unit 10 It is also possible to transfer to the storage container 23B via the bypass flow path F20.
  • the storage container 23A allows the cell suspension to flow in and out through the flow port 23a provided at the bottom thereof.
  • the storage container 23B allows the cell suspension to flow in and out through the circulation port 23b provided at the bottom.
  • the circulation ports 23a and 23b serve as the inflow port and the outflow port, so that one pipe can be connected to the storage containers 23A and 23B.
  • the circulation ports 23a and 23b at the bottoms of the storage containers 23A and 23B, respectively damage to the cells when the cell suspension is allowed to flow into the storage containers 23A and 23B can be suppressed.
  • the flow ports 23a and 23b at the bottoms of the storage containers 23A and 23B, respectively the cell suspension is stored in such a manner that the cell suspension is injected into the cell suspension already accumulated at the bottoms of the storage containers 23A and 23B. Cell suspension can be flowed into containers 23A and 23B.
  • the cell treatment device 1 includes a medium supply unit 51 connected to the first flow path F1.
  • the culture medium exchange process which replaces a used culture medium with a fresh culture medium is attained.
  • the cell processing apparatus 1 which concerns on exemplary embodiment of this invention has the culture medium supply part 52 connected to the 3rd flow path F3.
  • a culture medium can be added to the treated cell suspension recovered in the cell recovery container 100, and the amount of the culture medium can be adjusted after each process performed in the cell processing apparatus 1.
  • the cell processing apparatus 1 includes a cleaning liquid supply unit 60 connected to the cell supply unit 10.
  • a cleaning liquid supply unit 60 connected to the cell supply unit 10.
  • cleaning of the cell supply part 10, the filter part 21, etc. can be performed during a process, and the cells which remain
  • the loss of cells can be reduced.
  • the mode in which the cell collection container 100 is attached to the cell processing apparatus 1 is exemplified.
  • the mode in which the cell collection container 100 is attached to the third flow path F3 is used as the cell processing. It can also be regarded as a form of the device.
  • FIG. 7 and 8 are views showing a partial configuration of the cell processing apparatus according to the second exemplary embodiment of the present invention.
  • the cell treatment apparatus may include a plurality of filter units.
  • the filter unit 21A and the filter unit 21B are provided between the first channel F1 and the second channel F2. May be arranged in parallel. According to this configuration, the concentration process can be performed in parallel in the filter units 21A and 21B, and the concentration process can be performed efficiently.
  • the filter part 21A and the filter part 21B may be arranged in series between the first flow path F1 and the second flow path F2. According to this configuration, it is possible to continuously perform the concentration process by the filter unit 21A and the concentration process by the filter unit 21B with a single liquid feeding.
  • the filtering methods in the filter units 21A and 21B may be different from each other.
  • the filter unit 21A may be a filtration device that performs filtration by a tangential flow method
  • the filter unit 21B may be a filtration device that performs separation using centrifugal force.
  • the filtering methods in the filter units 21A and 21B may be the same as each other.
  • FIG. 9 is a diagram showing a configuration of a cell processing apparatus 1A according to the third exemplary embodiment of the present invention, in which the configuration of the cell processing apparatus 1 according to the first exemplary embodiment is simplified.
  • the cell treatment apparatus 1A corresponds to a configuration in which the agitation unit 40, the cleaning liquid supply unit 60, and the culture medium supply unit 52 are omitted from the cell treatment apparatus 1 according to the first exemplary embodiment.
  • the agitation unit 40, the cleaning liquid supply unit 60, and the culture medium supply unit 52 are omitted from the cell treatment apparatus 1 according to the first exemplary embodiment.
  • the cell processing apparatus 1 and 1A are examples of the cell processing apparatus in the technology of the present disclosure.
  • the cell supply unit 10 is an example of a cell supply unit in the technology of the present disclosure.
  • the concentration unit 20 is an example of a concentration unit in the technology of the present disclosure.
  • the dividing unit 30 is an example of a dividing unit in the technology of the present disclosure.
  • the first flow path F1 is an example of the first flow path in the technology of the present disclosure.
  • the second flow path F2 is an example of a second flow path in the technology of the present disclosure.
  • the third flow path F3 is an example of a third flow path in the technology of the present disclosure.
  • the filter unit 21 is an example of a filter unit in the technology of the present disclosure.
  • the cell collection container 100 is an example of cell collection in the technology of the present disclosure.
  • the bypass channel F10 is an example of a first bypass channel in the technology of the present disclosure.
  • the bypass channel F20 is an example of a second bypass channel in the technology of the present disclosure.
  • the storage container 23A is an example of a first storage container in the technology of the present disclosure.
  • the storage container 23B is an example of a second storage container in the technology of the present disclosure.
  • the distribution port 23a is an example of a first distribution port in the technology of the present disclosure.
  • the distribution port 23b is an example of a second distribution port in the technology of the present disclosure.
  • the stirring unit 40 is an example of a stirring unit in the technology of the present disclosure.
  • Pressurization device 24A and pressure control device 25A are examples of the 1st pressure control part in the art of this indication.
  • the pressurizing device 24B and the pressure control device 25B are an example of a second pressure control unit in the technology of the present disclosure.
  • the culture medium supply unit 51 is an example of a first culture medium supply unit in the technology of the present disclosure.
  • the culture medium supply unit 52 is an example of a second culture medium supply unit in the technology of the present disclosure.
  • the cleaning liquid supply unit 60 is an example of a cleaning liquid supply unit in the technology of the present disclosure.

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Water Supply & Treatment (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

The present disclosure provides a cell treatment device capable of lowering the risk of contamination due to the intermixture of cells before and after a division treatment. The cell treatment device includes: a concentration unit which is provided on the downstream side of a cell supply unit, is connected to the cell supply unit via a first flow passage and performs a concentration treatment for removing the liquid from a cell suspension including cells and a liquid accompanying the cells; and a division unit which is provided on the downstream side of the concentration unit, is connected to the concentration unit via a second flow passage and which performs a division treatment for dividing an aggregate of the cells.

Description

細胞処理装置Cell processing equipment

 本開示の技術は、細胞処理装置に関する。 The technology of the present disclosure relates to a cell processing apparatus.

 細胞処理装置(細胞培養装置)に関する技術として、例えば以下の技術が知られている。例えば、特開2010-011792号公報には、培養槽と、培養槽に連結されたフィルタ手段を有する分離装置と、分離装置に連結され、内部に貯留した液体培地を分離装置のフィルタ手段の表面に対して平行な方向に供給する培地移送槽とを備えた培養装置が記載されている。この培養装置は、培地移送槽と培養槽との間で液体培地を往復流動させることが可能とされている。 For example, the following techniques are known as techniques relating to cell processing apparatuses (cell culture apparatuses). For example, Japanese Patent Application Laid-Open No. 2010-011792 discloses a culture apparatus, a separation apparatus having filter means connected to the culture tank, and a liquid medium connected to the separation apparatus and stored in the surface of the filter means of the separation apparatus. The culture apparatus provided with the culture-medium transfer tank supplied in the direction parallel to is described. This culture apparatus can reciprocate a liquid medium between a medium transfer tank and a culture tank.

 一方、特開平01-206988号公報には、細胞等を含んだ培養液を循環または貯留して細胞の増殖を行う培養系と、培養系中の液状培地を連続的に新鮮培地と交換しうる液-補給・分離手段を備えた培養装置が記載されている。この培養装置には、培養液を一時この培養系の系外に迂回できる迂回流路が設けられており、この迂回流路に、培養液中の細胞等を透過するが細胞塊等を透過しえないフィルタを内蔵した筒状体からなる細胞塊除去部が設けられている。 On the other hand, Japanese Patent Application Laid-Open No. 01-206988 discloses a culture system in which a culture medium containing cells or the like is circulated or stored to proliferate cells, and the liquid medium in the culture system can be continuously replaced with a fresh medium. A culture apparatus with a liquid-replenishment / separation means is described. This culturing apparatus is provided with a bypass channel that can temporarily bypass the culture solution to the outside of the culture system. The bypass channel allows the cells in the culture solution to permeate but the cell mass or the like. There is provided a cell lump removing unit made of a cylindrical body with a built-in filter.

 多能性幹細胞の培養においては、細胞を培養することによって生じる細胞凝集体(スフェア)のサイズが過大となると、細胞凝集体同士が接着融合し、細胞が分化を開始したり、細胞凝集体の中の細胞が壊死したりする。従って、細胞凝集体のサイズが過大となることを防止するために、細胞の培養期間中の適切な時期に、細胞凝集体を分割する分割処理が必要となる。また、細胞培養においては、細胞から分泌される代謝物などによって培地が変質する。そのため、培養期間中における適切な時期に、培養容器内における使用済みの培地を新鮮な培地に交換する培地交換処理が必要となる。また、細胞培養においては、細胞懸濁液に含まれる細胞の濃度を所望の濃度にまで濃縮する濃縮処理が必要となる。 In the culture of pluripotent stem cells, when the size of cell aggregates (spheres) generated by culturing cells becomes excessive, the cell aggregates adhere to each other and cells start to differentiate, The cells inside are necrotic. Therefore, in order to prevent the size of the cell aggregate from becoming excessive, a dividing process for dividing the cell aggregate is required at an appropriate time during the cell culture period. In cell culture, the medium is altered by metabolites secreted from the cells. Therefore, it is necessary to perform a medium exchange process in which a used medium in the culture container is replaced with a fresh medium at an appropriate time during the culture period. Further, in cell culture, a concentration process for concentrating the concentration of cells contained in the cell suspension to a desired concentration is required.

 上記の分割処理、培地交換処理および濃縮処理を含む一連の細胞培養プロセスを自動化する細胞処理装置の構成として以下の構成が考えられる。例えば、上記の各処理を実施するための処理ユニットおよび細胞培養容器を、環状の循環流路上または循環流路から分岐した分岐流路上に適宜配置する構成が考えられる。しかしながら、この構成によれば、環状の循環流路を各処理において共有することになり、分割処理前後の細胞が混ざり合ういわゆるコンタミネーションのリスクが高いと考えられる。例えば、循環流路を経由して細胞懸濁液を移送している間に循環流路の壁面に付着した一部の細胞については分割処理が実施されず、この細胞が循環流路を経由して分割処理済みの細胞に混入するおそれがある。特に、再生医療に用いられる培養細胞は、同一ロット内における細胞の均質性を保証する必要があるため、分割処理前後の細胞が混ざり合うコンタミネーションのリスクを低減することが重要である。 The following configuration can be considered as a configuration of a cell processing apparatus that automates a series of cell culture processes including the above-described division processing, medium replacement processing, and concentration processing. For example, the structure which arrange | positions suitably the processing unit and cell culture container for implementing each said process on the cyclic | annular circulation flow path or the branched flow path branched from the circulation flow path can be considered. However, according to this configuration, an annular circulation channel is shared in each process, and it is considered that there is a high risk of so-called contamination in which cells before and after the division process are mixed. For example, some cells attached to the wall surface of the circulation channel while the cell suspension is being transferred through the circulation channel are not subjected to the division process, and these cells are not transmitted through the circulation channel. There is a risk of mixing into cells that have been split. In particular, since cultured cells used for regenerative medicine need to guarantee the homogeneity of cells in the same lot, it is important to reduce the risk of contamination in which cells before and after the division process are mixed.

 本開示の技術は、分割処理前後の細胞が混ざり合うコンタミネーションのリスクを低減できる細胞処理装置を提供する。 The technology of the present disclosure provides a cell processing apparatus that can reduce the risk of contamination in which cells before and after division processing are mixed.

 本開示の第1の態様は、細胞処理装置であって、細胞を供給する細胞供給部と、細胞供給部の下流側に設けられて第1の流路を介して細胞供給部に接続され、細胞および細胞に随伴する液体を含む細胞懸濁液から液体を除去する濃縮処理を行う濃縮部と、濃縮部の下流側に設けられて第2の流路を介して濃縮部に接続され、細胞の凝集体を分割する分割処理を行う分割部と、を含む。 A first aspect of the present disclosure is a cell processing apparatus, a cell supply unit that supplies cells, and a downstream side of the cell supply unit, and is connected to the cell supply unit via a first flow path, A concentration unit that performs a concentration process for removing the liquid from the cell suspension containing the cells and the liquid accompanying the cell, and is connected to the concentration unit via the second channel provided downstream of the concentration unit, A dividing unit that performs a dividing process of dividing the aggregate.

 本開示の第2の態様は、上記態様において、第1の流路は、第1の流路を通過する細胞懸濁液が上流側から下流側に向けて流れる一方通行の流路であることが好ましく、第2の流路は、第2の流路を通過する細胞懸濁液が上流側から下流側に向けて流れる一方通行の流路であることが好ましい。 In a second aspect of the present disclosure, in the above aspect, the first flow path is a one-way flow path in which the cell suspension passing through the first flow path flows from the upstream side toward the downstream side. Preferably, the second channel is a one-way channel in which the cell suspension passing through the second channel flows from the upstream side toward the downstream side.

 本開示の第3の態様は、上記第2の態様において、濃縮部は、一方の流通口が第1の流路に接続され、他方の流通口が第2の流路に接続され、一方の流通口または他方の流通口から流入する細胞懸濁液に対して濃縮処理を施して、一方の流通口および他方の流通口のうち細胞懸濁液が流入した流通口とは異なる流通口から濃縮処理を施した細胞懸濁液を排出するフィルタ部を含んでいてもよい。 According to a third aspect of the present disclosure, in the second aspect, the concentrating unit has one flow port connected to the first flow channel, the other flow port connected to the second flow channel, Concentrate the cell suspension flowing from the flow port or the other flow port, and concentrate from one of the flow ports and the other flow port that is different from the flow port into which the cell suspension flows. A filter unit for discharging the treated cell suspension may be included.

 本開示の第4の態様は、上記第3の態様において、分割部は、分割処理を施した細胞を排出する排出口を含んでいてもよい。この場合、本開示の第4の態様は、排出口に接続された第3の流路と、第3の流路に接続された細胞回収容器と、を含んでいてもよい。 In the fourth aspect of the present disclosure, in the third aspect, the dividing unit may include a discharge port for discharging the cells subjected to the dividing process. In this case, the fourth aspect of the present disclosure may include a third flow path connected to the discharge port and a cell recovery container connected to the third flow path.

 本開示の第5の態様は、上記第4の態様において、一端が第2の流路に接続され、他端が第3の流路に接続された第1のバイパス流路を含んでいてもよい。 The fifth aspect of the present disclosure may include the first bypass flow path having one end connected to the second flow path and the other end connected to the third flow path in the fourth aspect. Good.

 本開示の第6の態様は、上記第1の態様において、濃縮部は、第1の流路に接続された第1の貯留容器と、第2の流路に接続された第2の貯留容器と、を含んでいてもよい。 According to a sixth aspect of the present disclosure, in the first aspect, the concentration unit includes a first storage container connected to the first flow path, and a second storage container connected to the second flow path. And may be included.

 本開示の第7の態様は、上記第6の態様において、第1の貯留容器は、第1の流路に接続された第1の流通口を介して細胞懸濁液を流入および流出させ、第2の貯留容器は、第2の流路に接続された第2の流通口を介して細胞懸濁液を流入および流出させることが好ましい。また、本開示の第8の態様は、上記第7の態様において、第1の流通口は、第1の貯留容器の底部に設けられ、第2の流通口は、第2の貯留容器の底部に設けられていることが好ましい。 According to a seventh aspect of the present disclosure, in the sixth aspect, the first storage container causes the cell suspension to flow in and out via the first circulation port connected to the first flow path. The second storage container preferably allows the cell suspension to flow in and out through the second flow port connected to the second flow path. Further, according to an eighth aspect of the present disclosure, in the seventh aspect, the first circulation port is provided at a bottom portion of the first storage container, and the second circulation port is a bottom portion of the second storage container. Is preferably provided.

 本開示の第9の態様は、上記第6~第8の態様において、第1の貯留容器の内部の圧力を制御する第1の圧力制御部と、第2の貯留容器の内部の圧力を制御する第2の圧力制御部と、を含んでいてもよい。 According to a ninth aspect of the present disclosure, in the sixth to eighth aspects, the first pressure control unit that controls the pressure inside the first storage container and the pressure inside the second storage container are controlled. And a second pressure control unit.

 本開示の第10の態様は、上記第1の態様において、一方の端部が第1の流路に接続され、他方の端部が第2の流路に接続され、一方の端部または他方の端部から流入する細胞懸濁液に対して撹拌処理を施して、一方の端部および他方の端部のうち細胞懸濁液が流入した端部とは異なる端部から撹拌処理を施した細胞懸濁液を排出する撹拌部を含んでいてもよい。本開示の第11の態様は、上記第10の態様において、撹拌部は、スタティックミキサを含んで構成されていてもよい。 According to a tenth aspect of the present disclosure, in the first aspect, one end is connected to the first flow path, the other end is connected to the second flow path, and one end or the other is connected. The cell suspension flowing in from the end of the cell was subjected to stirring treatment, and the stirring treatment was performed from one end and the other end different from the end into which the cell suspension flowed An agitation part for discharging the cell suspension may be included. According to an eleventh aspect of the present disclosure, in the tenth aspect, the stirring unit may include a static mixer.

 本開示の第12の態様は、上記第3~第6、第10の態様において、一端が第1の流路に接続され、他端が第2の流路に接続された第2のバイパス流路を含んでいてもよい。 According to a twelfth aspect of the present disclosure, in the third to sixth and tenth aspects, the second bypass flow having one end connected to the first flow path and the other end connected to the second flow path. It may contain roads.

 本開示の第13の態様は、上記態様において、濃縮部は、第1の流路と第2の流路との間に、互いに直列または並列に配置された複数のフィルタ部を含んでいてもよい。 In a thirteenth aspect of the present disclosure, in the above aspect, the concentration unit may include a plurality of filter units arranged in series or in parallel with each other between the first channel and the second channel. Good.

 本開示の第14、第15の態様は、上記態様において、フィルタ部は、タンジェンシャルフロー方式による濾過を行うものであってもよく、遠心力を利用した分離を行うものであってもよい。 In the fourteenth and fifteenth aspects of the present disclosure, in the above aspect, the filter unit may perform filtration using a tangential flow method, or may perform separation using centrifugal force.

 本開示の第16の態様は、上記第13の態様において、濃縮部が複数のフィルタ部を含む場合、濃縮部は、タンジェンシャルフロー方式による濾過を行う第1のフィルタ部と、遠心力を利用した分離を行う第2のフィルタ部と、を含んでいてもよい。 According to a sixteenth aspect of the present disclosure, in the thirteenth aspect, when the concentration unit includes a plurality of filter units, the concentration unit uses a first filter unit that performs filtration by a tangential flow method and a centrifugal force. And a second filter unit that performs the separation.

 本開示の第17の態様は、上記態様において、第1の流路に接続された第1の培地供給部を含んでいてもよい。 The seventeenth aspect of the present disclosure may include a first medium supply unit connected to the first flow path in the above aspect.

 本開示の第18の態様は、上記第4、第5の態様において、第3の流路に接続された第2の培地供給部を含んでいてもよい。 The eighteenth aspect of the present disclosure may include a second culture medium supply unit connected to the third flow path in the fourth and fifth aspects.

 本開示の第19の態様は、上記態様において、細胞供給部に洗浄液を供給する洗浄液供給部を含んでいてもよい。 The nineteenth aspect of the present disclosure may include a cleaning liquid supply unit that supplies a cleaning liquid to the cell supply unit in the above aspect.

 本開示の上記態様によれば、分割処理前後の細胞が混ざり合うコンタミネーションのリスクを低減できる細胞処理装置を提供できる。 According to the above aspect of the present disclosure, it is possible to provide a cell treatment apparatus that can reduce the risk of contamination in which cells before and after the division treatment are mixed.

本発明の例示的実施形態に係る細胞処理装置の構成を示す図である。It is a figure which shows the structure of the cell processing apparatus which concerns on exemplary embodiment of this invention. 本発明の例示的実施形態に係るフィルタ部における濾過の態様の一例を示す図である。It is a figure which shows an example of the aspect of filtration in the filter part which concerns on exemplary embodiment of this invention. 本発明の例示的実施形態に係る細胞処理装置の使用形態の一例を示す図である。It is a figure which shows an example of the usage condition of the cell processing apparatus which concerns on exemplary embodiment of this invention. 本発明の例示的実施形態に係る細胞処理装置が分割処理を実施する場合における細胞及び培地等の流れを示す図である。It is a figure which shows the flow of a cell, a culture medium, etc. in case the cell processing apparatus which concerns on exemplary embodiment of this invention performs a division | segmentation process. 本発明の例示的実施形態に係る細胞処理装置が培地交換処理を実施する場合における細胞及び培地等の流れを示す図である。It is a figure which shows the flow of a cell, a culture medium, etc. in case the cell processing apparatus which concerns on exemplary embodiment of this invention implements a culture medium exchange process. 本発明の例示的実施形態に係る細胞処理装置が濃縮処理を実施する場合における細胞及び培地等の流れを示す図である。It is a figure which shows the flow of a cell, a culture medium, etc. in case the cell processing apparatus which concerns on exemplary embodiment of this invention implements a concentration process. 本発明の他の例示的実施形態に係る細胞処理装置の部分的な構成を示す図である。It is a figure which shows the partial structure of the cell processing apparatus which concerns on other exemplary embodiment of this invention. 本発明の他の例示的実施形態に係る細胞処理装置の部分的な構成を示す図である。It is a figure which shows the partial structure of the cell processing apparatus which concerns on other exemplary embodiment of this invention. 本発明の他の例示的実施形態に係る細胞処理装置の構成を示す図である。It is a figure which shows the structure of the cell processing apparatus which concerns on other exemplary embodiment of this invention.

 以下、本発明の例示的実施形態の一例を、図面を参照しつつ説明する。なお、各図面において同一または等価な構成要素および部分には同一の参照符号を付与し、重複する説明は省略する。 Hereinafter, an exemplary embodiment of the present invention will be described with reference to the drawings. In the drawings, the same or equivalent components and parts are denoted by the same reference numerals, and redundant description is omitted.

[第1の例示的実施形態]
 図1は、本発明の第1の例示的実施形態に係る細胞処理装置1の構成を示す図である。細胞処理装置1は、主要な構成要素として、細胞供給部10、濃縮部20および分割部30を備えている。細胞処理装置1は、更に、培地供給部51、52、洗浄液供給部60および撹拌部40を備えている。
[First exemplary embodiment]
FIG. 1 is a diagram showing a configuration of a cell processing apparatus 1 according to a first exemplary embodiment of the present invention. The cell processing apparatus 1 includes a cell supply unit 10, a concentration unit 20, and a division unit 30 as main components. The cell treatment apparatus 1 further includes medium supply units 51 and 52, a cleaning liquid supply unit 60, and a stirring unit 40.

 細胞供給部10は、細胞処理装置1によって実施される各処理の対象となる細胞を供給する。細胞供給部10は、細胞を収容する収容容器を含んで構成されている。細胞供給部10は、その底部に設けられた流通口10aから細胞を排出する。流通口10aは、バルブV1を介して第1の流路F1に接続されている。バルブV1は、細胞供給部10に収容された細胞を第1の流路F1に流出させる場合に開状態とされ、それ以外の場合には閉状態とされる。 The cell supply unit 10 supplies cells to be processed by the cell processing apparatus 1. The cell supply part 10 is comprised including the storage container which accommodates a cell. The cell supply unit 10 discharges cells from the circulation port 10a provided at the bottom. The circulation port 10a is connected to the first flow path F1 through the valve V1. The valve V1 is opened when the cells accommodated in the cell supply unit 10 are allowed to flow out to the first flow path F1, and is closed otherwise.

 濃縮部20は、細胞供給部10の下流側に設けられ、第1の流路F1を介して細胞供給部10に接続されている。濃縮部20は、細胞および細胞に随伴する液体(例えば培地)を含む細胞懸濁液から液体および細胞凝集体から離脱してシングルセル化した死細胞等のデブリスを除去することにより、細胞懸濁液に含まれる細胞の濃度を高める濃縮処理を行う。濃縮部20は、フィルタ部21、濾過液回収容器22および2つの貯留容器23A、23Bを含んで構成されている。 The concentration unit 20 is provided on the downstream side of the cell supply unit 10 and is connected to the cell supply unit 10 via the first flow path F1. The concentration unit 20 removes debris such as dead cells that have separated from the liquid and cell aggregates into a single cell from a cell suspension containing cells and a liquid (for example, a medium) associated with the cell, thereby suspending the cell suspension. Concentration treatment is performed to increase the concentration of cells contained in the solution. The concentrating unit 20 includes a filter unit 21, a filtrate recovery container 22, and two storage containers 23A and 23B.

 フィルタ部21は、バルブV2を介して第1の流路F1に接続された流通口21aと、バルブV3を介して第2の流路F2に接続された流通口21bとを有する。フィルタ部21は、流通口21aまたは21bから流入する細胞懸濁液に対して濃縮処理を施して、細胞懸濁液が流入した流通口とは異なる流通口から濃縮処理を施した細胞懸濁液を排出する。例えば、流通口21aからフィルタ部21に流入した細胞懸濁液は、フィルタ部21において濃縮処理が施され、濃縮処理済みの細胞懸濁液が流通口21bから排出される。 The filter unit 21 has a flow port 21a connected to the first flow path F1 via the valve V2, and a flow port 21b connected to the second flow path F2 via the valve V3. The filter unit 21 performs a concentration process on the cell suspension flowing from the flow port 21a or 21b, and performs a concentration process from a flow port different from the flow port into which the cell suspension flows. Is discharged. For example, the cell suspension that has flowed into the filter unit 21 from the flow port 21a is concentrated in the filter unit 21, and the cell suspension that has been subjected to the concentration process is discharged from the flow port 21b.

 フィルタ部21は、例えば、タンジェンシャルフロー(クロスフロー)方式による濾過を行う濾過装置を構成するものであり、濾過装置の内部に配置された濾過膜の膜面に沿って細胞懸濁液が流れるように構成されている。図2は、フィルタ部21における濾過の態様の一例を示す図である。フィルタ部21は、例えば、中空糸からなる濾過膜Mを有する。濾過膜Mは、多孔質膜であってもよく、濾過膜Mの材質は、金属、ポリマーまたはセラミックス焼結体などであってもよい。細胞Cおよび培地等の液体Lを含む細胞懸濁液が流通口21aまたは21bを介して濾過膜Mの内側に流入すると、液体Lは、濾過膜Mの外側に排出されて濾過液回収容器22に収容される。一方、細胞Cは、濾過膜Mの内側を通過して流通口21aまたは21bから排出されて回収される。なお、フィルタ部21は、細胞懸濁液の流れ方向が、濾過膜の膜面に対して交差する方向となるデッドエンドフロー方式による濾過を行うものであってもよい。また、フィルタ部21は、遠心力を利用した分離を行うものであってもよい。 The filter unit 21 constitutes, for example, a filtration device that performs filtration by a tangential flow (cross flow) method, and the cell suspension flows along the membrane surface of the filtration membrane disposed inside the filtration device. It is configured as follows. FIG. 2 is a diagram illustrating an example of a filtration mode in the filter unit 21. The filter part 21 has the filtration membrane M which consists of hollow fibers, for example. The filtration membrane M may be a porous membrane, and the material of the filtration membrane M may be a metal, a polymer, a ceramic sintered body, or the like. When a cell suspension containing cells C and a liquid L such as a medium flows into the inside of the filtration membrane M via the flow port 21a or 21b, the liquid L is discharged to the outside of the filtration membrane M and the filtrate collection container 22 Is housed in. On the other hand, the cell C passes through the inside of the filtration membrane M, is discharged from the flow port 21a or 21b, and is collected. The filter unit 21 may perform filtration by a dead end flow method in which the cell suspension flow direction intersects the membrane surface of the filtration membrane. The filter unit 21 may perform separation using centrifugal force.

 バルブV2およびV3は、フィルタ部21において濃縮処理を行う場合に開状態とされ、それ以外の場合は閉状態とされる。 Valves V2 and V3 are open when the concentration process is performed in the filter unit 21, and are closed otherwise.

 貯留容器23Aおよび23Bは、細胞処理装置1において実施される各処理の対象となる細胞懸濁液を一時的に貯留しておくための容器である。貯留容器23Aおよび23Bの形態は、特に限定されず、例えば、ガラス製若しくはステンレス製の容器、またはプラスチック製のバッグの形態を有する容器を使用することが可能である。 The storage containers 23 </ b> A and 23 </ b> B are containers for temporarily storing a cell suspension that is a target of each process performed in the cell processing apparatus 1. The form of the storage containers 23A and 23B is not particularly limited, and for example, a glass or stainless steel container or a container having a plastic bag form can be used.

 貯留容器23Aは、その底部に設けられた流通口23aを有し、流通口23aを経由して細胞懸濁液が流入または流出する。すなわち、流通口23aは、貯留容器23Aの流入口の役割と流出口の役割とを兼ねている。流通口23aは、バルブV4を介して第1の流路F1に接続されている。バルブV4は、貯留容器23Aに細胞懸濁液を流入させる場合または貯留容器23Aから細胞懸濁液を流出させる場合に開状態とされ、それ以外の場合には閉状態とされる。 The storage container 23A has a flow port 23a provided at the bottom thereof, and the cell suspension flows in or out through the flow port 23a. That is, the distribution port 23a serves both as an inlet and an outlet of the storage container 23A. The circulation port 23a is connected to the first flow path F1 through the valve V4. The valve V4 is opened when the cell suspension is allowed to flow into the storage container 23A or when the cell suspension is allowed to flow out of the storage container 23A, and is otherwise closed.

 同様に、貯留容器23Bは、その底部に設けられた流通口23bを有し、流通口23bを経由して細胞懸濁液が流入または流出する。すなわち、流通口23bは、貯留容器23Bの流入口の役割と流出口の役割とを兼ねている。流通口23bは、バルブV5を介して第2の流路F2に接続されている。バルブV5は、貯留容器23Bに細胞懸濁液を流入させる場合または貯留容器23Bから細胞懸濁液を流出させる場合に開状態とされ、それ以外の場合には閉状態とされる。 Similarly, the storage container 23B has a flow port 23b provided at the bottom thereof, and the cell suspension flows in or out through the flow port 23b. That is, the circulation port 23b serves both as an inlet and an outlet of the storage container 23B. The circulation port 23b is connected to the second flow path F2 through the valve V5. The valve V5 is opened when the cell suspension is caused to flow into the storage container 23B or when the cell suspension is caused to flow out of the storage container 23B, and is otherwise closed.

 貯留容器23Aには、加圧装置24Aおよび圧力制御装置25Aが設けられている。加圧装置24Aは、貯留容器23Aの内部を加圧する機能を有する。圧力制御装置25Aは、加圧装置24Aが貯留容器23Aの内部を加圧する圧力を制御する。 The storage container 23A is provided with a pressurizing device 24A and a pressure control device 25A. The pressurizing device 24A has a function of pressurizing the inside of the storage container 23A. The pressure control device 25A controls the pressure at which the pressurizing device 24A pressurizes the inside of the storage container 23A.

 同様に、貯留容器23Bには、加圧装置24Bおよび圧力制御装置25Bが設けられている。加圧装置24Bは、貯留容器23Bの内部を加圧する機能を有する。圧力制御装置25Bは、加圧装置24Bが貯留容器23Bの内部を加圧する圧力を制御する。 Similarly, a pressurizing device 24B and a pressure control device 25B are provided in the storage container 23B. The pressurizing device 24B has a function of pressurizing the inside of the storage container 23B. The pressure control device 25B controls the pressure at which the pressurizing device 24B pressurizes the inside of the storage container 23B.

 圧力制御装置25Aおよび25Bによる圧力制御によって、貯留容器23Aと貯留容器23Bとの間で相互に細胞懸濁液の移送が可能である。例えば、貯留容器23Aの内部の圧力を貯留容器23Bの内部の圧力よりも高くすることで、貯留容器23Aに貯留された細胞懸濁液を貯留容器23Bに移送することが可能である。また、貯留容器23Bの内部の圧力を貯留容器23Aの内部の圧力よりも高くすることで、貯留容器23Bに貯留された細胞懸濁液を貯留容器23Aに移送することが可能である。なお、本実施例では、貯留容器23Aおよび23Bの内部の圧力を加圧する加圧手段によって貯留容器23Aおよび23Bにおいて圧力差を生じさせて細胞懸濁液の移送を行う場合を例示したが、この態様に限定されるものではない。他の例として、貯留容器23Aおよび23Bの内部の圧力を減圧する減圧手段によって貯留容器23Aおよび23Bにおいて圧力差を生じさせて細胞懸濁液の移送を行ってもよい。また、加圧手段と減圧手段との組み合わせによって貯留容器23Aおよび23Bにおいて圧力差を生じさせて細胞懸濁液の移送を行ってもよい。 The cell suspension can be transferred between the storage container 23A and the storage container 23B by pressure control by the pressure control devices 25A and 25B. For example, by making the pressure inside the storage container 23A higher than the pressure inside the storage container 23B, the cell suspension stored in the storage container 23A can be transferred to the storage container 23B. Further, by making the pressure inside the storage container 23B higher than the pressure inside the storage container 23A, the cell suspension stored in the storage container 23B can be transferred to the storage container 23A. In the present embodiment, the case where the cell suspension is transferred by causing a pressure difference in the storage containers 23A and 23B by the pressurizing means that pressurizes the pressure inside the storage containers 23A and 23B is illustrated. It is not limited to the embodiment. As another example, the cell suspension may be transferred by generating a pressure difference in the storage containers 23A and 23B by a decompression unit that reduces the pressure inside the storage containers 23A and 23B. Further, the cell suspension may be transferred by generating a pressure difference in the storage containers 23A and 23B by a combination of the pressurizing means and the decompressing means.

 貯留容器23Aと貯留容器23Bとの間で細胞懸濁液を往復移動させることも可能であり、この場合に細胞懸濁液がフィルタ部21を通過することで、フィルタ部21による濃縮処理を複数回に亘り連続的に実施することが可能となる。従って、貯留容器23Aと貯留容器23Bとの間での細胞懸濁液の往復移動回数によって、細胞懸濁液の濃度を調整することができる。 It is also possible to reciprocate the cell suspension between the storage container 23A and the storage container 23B. In this case, the cell suspension passes through the filter unit 21, thereby performing a plurality of concentration processes by the filter unit 21. It becomes possible to carry out continuously over time. Therefore, the concentration of the cell suspension can be adjusted by the number of reciprocating movements of the cell suspension between the storage container 23A and the storage container 23B.

 撹拌部40は、流入する細胞懸濁液を撹拌する機能を有する。撹拌部40の一方の端部は、バルブV9を介して第1の流路F1に接続され、撹拌部40の他方の端部は、バルブV10を介して第2の流路F2に接続されている。撹拌部40は、一方の端部または他方の端部から流入する細胞懸濁液に対して撹拌処理を施して細胞懸濁液が流入した端部とは異なる端部から撹拌処理を施した細胞懸濁液を排出する。 The stirring unit 40 has a function of stirring the flowing cell suspension. One end of the stirring unit 40 is connected to the first flow path F1 through the valve V9, and the other end of the stirring unit 40 is connected to the second flow path F2 through the valve V10. Yes. The agitation unit 40 performs the agitation process on the cell suspension flowing from one end or the other end, and performs the agitation process from an end different from the end into which the cell suspension has flowed. Drain the suspension.

 撹拌部40は、駆動部を有しない所謂スタティックミキサとしての構成を有していることが好ましく、例えば、管状体と、管状体の内部に固定設置され、管状体の内部にらせん状の流路を形成する撹拌エレメントと、を含んで構成される。なお、スタティックミキサを構成する管状体の内部の流路は、必ずしもらせん状であることを要しない。また、スタティックミキサは、管状体の内部を通過する流体を撹拌し得るように、管状体の内径を変化させた構造を有するものであってもよい。 The stirrer 40 preferably has a configuration as a so-called static mixer that does not have a drive unit. For example, the agitator 40 is fixedly installed inside the tubular body and inside the tubular body, and has a spiral flow path inside the tubular body. And a stirring element that forms the structure. The flow path inside the tubular body constituting the static mixer does not necessarily need to be spiral. The static mixer may have a structure in which the inner diameter of the tubular body is changed so that the fluid passing through the inside of the tubular body can be stirred.

 バルブV9およびV10は、撹拌部40において撹拌処理を行う場合に開状態とされ、それ以外の場合は閉状態とされる。 Valves V9 and V10 are opened when stirring is performed in the stirring section 40, and are closed otherwise.

 細胞処理装置1は、第1の流路F1と第2の流路F2との間にバイパス流路F20を有する。すなわち、バイパス流路F20の一端は、バルブV11を介して第1の流路F1に接続されており、バイパス流路F20の他端は、バルブV12を介して第2の流路F2に接続されている。 The cell treatment device 1 has a bypass channel F20 between the first channel F1 and the second channel F2. That is, one end of the bypass flow path F20 is connected to the first flow path F1 via the valve V11, and the other end of the bypass flow path F20 is connected to the second flow path F2 via the valve V12. ing.

 バルブV11およびV12は、バイパス流路F20に細胞懸濁液を流す場合に開状態とされ、それ以外の場合は閉状態とされる。 Valves V11 and V12 are opened when the cell suspension is passed through the bypass flow path F20, and are closed otherwise.

 以上のように、細胞処理装置1において、第1の流路F1および第2の流路F2との間に、フィルタ部21、撹拌部40およびバイパス流路F20が並列に配置されており、これらを選択的に使用することが可能である。すなわち、第1の流路F1を介して供給される細胞懸濁液は、第2の流路F2に移送されるまでの間に、フィルタ部21、撹拌部40およびバイパス流路F20のいずれをも経由することが可能である。 As described above, in the cell treatment apparatus 1, the filter unit 21, the stirring unit 40, and the bypass channel F20 are arranged in parallel between the first channel F1 and the second channel F2. Can be selectively used. That is, the cell suspension supplied through the first flow path F1 passes through the filter section 21, the stirring section 40, and the bypass flow path F20 before being transferred to the second flow path F2. Is also possible.

 分割部30は、細胞を培養することによって形成される細胞凝集体を分割する分割処理を行う機能を有する。分割部30において行われる分割処理は、機械的分割処理であってもよいし、細胞解離酵素を用いた酵素処理であってもよい。機械的分割処理が適用される場合には、分割部30は、処理容器と、処理容器の内部に設けられたメッシュフィルタを含んで構成される。細胞凝集体を含む細胞懸濁液をメッシュフィルタに通すことで、細胞凝集体はメッシュフィルタのメッシュサイズに応じたサイズに分割される。なお、細胞凝集体を分割する手段としてメッシュフィルタ以外に多孔板または貫通孔板を用いることが可能である。一方、酵素処理による分割処理が適用される場合には、分割部30は、トリプシン-EDTA(ethylenediaminetetraa cetic acid)等の細胞解離酵素が収容された処理容器を含んで構成される。細胞凝集体を一定時間に亘り細胞解離酵素に浸漬することで、細胞凝集体が分割される The dividing unit 30 has a function of performing a dividing process of dividing a cell aggregate formed by culturing cells. The dividing process performed in the dividing unit 30 may be a mechanical dividing process or an enzyme process using a cell dissociating enzyme. When the mechanical division process is applied, the dividing unit 30 includes a processing container and a mesh filter provided inside the processing container. By passing the cell suspension containing the cell aggregate through the mesh filter, the cell aggregate is divided into sizes according to the mesh size of the mesh filter. In addition to the mesh filter, a porous plate or a through-hole plate can be used as a means for dividing the cell aggregate. On the other hand, when the division process by the enzyme process is applied, the division unit 30 includes a treatment container in which a cell dissociation enzyme such as trypsin-EDTA (ethylenediaminetetraacetic acid) is accommodated. Cell aggregates are divided by immersing the cell aggregates in a cell dissociation enzyme for a certain period of time

 分割部30は、バルブV13を介して第2の流路F2に接続された流入口30aと、バルブV14を介して第3の流路F3に接続された流出口30bとを有する。分割部30は、流入口30aから流入する細胞懸濁液に含まれる細胞凝集体に対して分割処理を施して、分割処理を施した細胞凝集体を含む細胞懸濁液を流出口30bから排出する。 The dividing unit 30 has an inlet 30a connected to the second flow path F2 via the valve V13 and an outlet 30b connected to the third flow path F3 via the valve V14. The dividing unit 30 performs a dividing process on the cell aggregate included in the cell suspension flowing in from the inflow port 30a, and discharges the cell suspension including the cell aggregate subjected to the dividing process from the outflow port 30b. To do.

 バルブV13およびV14は、分割部30において分割処理を行う場合に開状態とされ、それ以外の場合は閉状態とされる。 Valves V13 and V14 are opened when the dividing unit 30 performs division processing, and are otherwise closed.

 細胞処理装置1は、第2の流路F2と第3の流路F3との間にバイパス流路F10を有する。すなわち、バイパス流路F10の一端は、バルブV15を介して第2の流路F2に接続されており、バイパス流路F10の他端は、バルブV16を介して第3の流路F3に接続されている。 The cell treatment device 1 has a bypass channel F10 between the second channel F2 and the third channel F3. That is, one end of the bypass flow path F10 is connected to the second flow path F2 via the valve V15, and the other end of the bypass flow path F10 is connected to the third flow path F3 via the valve V16. ing.

 バルブV15およびV16は、バイパス流路F10に細胞懸濁液を流す場合に開状態とされ、それ以外の場合は閉状態とされる。 Valves V15 and V16 are opened when the cell suspension is passed through the bypass flow path F10, and are closed otherwise.

 細胞処理装置1は、2つの培地供給部51および52を有する。培地供給部51は、新鮮な培地を収容する収容容器を含んで構成されている。培地供給部51は、その底部に設けられた排出口51aから培地を排出する。排出口51aは、バルブV17を介して第1の流路F1に接続されている。バルブV17は、培地供給部51に収容された培地を第1の流路F1に流出させる場合に開状態とされ、それ以外の場合には閉状態とされる。なお、排出口51aは、培地供給部51の底部以外の位置に配置することが可能である。 The cell treatment apparatus 1 has two medium supply parts 51 and 52. The culture medium supply unit 51 includes a storage container that stores a fresh culture medium. The culture medium supply part 51 discharges | emits a culture medium from the discharge port 51a provided in the bottom part. The discharge port 51a is connected to the first flow path F1 through the valve V17. The valve V <b> 17 is opened when the medium stored in the medium supply unit 51 flows out to the first flow path F <b> 1, and is closed otherwise. The discharge port 51a can be disposed at a position other than the bottom of the medium supply unit 51.

 培地供給部52は、その底部に設けられた排出口52aから培地を排出する。排出口52aは、バルブV18を介して第3の流路F3に接続されている。バルブV18は、培地供給部52に収容された培地を第3の流路F3に流出させる場合に開状態とされ、それ以外の場合には閉状態とされる。なお、排出口52aは、培地供給部52の底部以外の位置に配置することが可能である。 The medium supply unit 52 discharges the medium from the discharge port 52a provided at the bottom. The discharge port 52a is connected to the third flow path F3 through the valve V18. The valve V18 is opened when the medium accommodated in the medium supply unit 52 is caused to flow out to the third flow path F3, and is closed otherwise. The discharge port 52a can be disposed at a position other than the bottom of the medium supply unit 52.

 洗浄液供給部60は、細胞供給部10およびフィルタ部21を洗浄するための洗浄液を収容する収容容器を含んで構成されている。洗浄液供給部60は、バルブV19を介して細胞供給部10に接続されている。 The cleaning liquid supply unit 60 includes a storage container that stores a cleaning liquid for cleaning the cell supply unit 10 and the filter unit 21. The cleaning liquid supply unit 60 is connected to the cell supply unit 10 via the valve V19.

 バルブV19は、洗浄液供給部60に収容された洗浄液による洗浄を行う場合に開状態とされ、それ以外の場合には閉状態とされる。バルブV19が開状態となることで、洗浄液供給部60に収容された洗浄液が細胞供給部10に流入し、細胞供給部10を構成する容器の内部が洗浄される。これにより細胞供給部10に残留する細胞を洗浄液の液流によって掻きとって回収することが可能である。 The valve V19 is opened when cleaning with the cleaning liquid stored in the cleaning liquid supply unit 60, and is closed otherwise. By opening the valve V19, the cleaning liquid stored in the cleaning liquid supply unit 60 flows into the cell supply unit 10, and the inside of the container constituting the cell supply unit 10 is cleaned. As a result, the cells remaining in the cell supply unit 10 can be scraped and collected by the flow of the washing liquid.

 洗浄液供給部60に収容された洗浄液をフィルタ部21に供給することで、フィルタ部21の洗浄を行うことも可能である。洗浄液をフィルタ部21に流すことで、フィルタ部21に設けられた濾過膜の膜面に残留する細胞を洗浄液の液流によって掻きとって回収することが可能である。なお、培地供給部51および52に収容された培地と同じ培地を洗浄液として用いることが可能である。 It is also possible to clean the filter part 21 by supplying the cleaning liquid stored in the cleaning liquid supply part 60 to the filter part 21. By flowing the washing liquid through the filter unit 21, cells remaining on the membrane surface of the filtration membrane provided in the filter unit 21 can be scraped and collected by the washing liquid flow. In addition, it is possible to use the same culture medium as the culture medium accommodated in the culture medium supply units 51 and 52 as the cleaning liquid.

 細胞回収容器100は、細胞処理装置1によって処理された細胞懸濁液を回収するための容器である。細胞回収容器100の形態は、特に限定されず、例えば、ガラス製またはステンレス製の容器やプラスチック製のバッグの形態を有する容器を使用することが可能である。図1に示すように、細胞回収容器100を第3の流路F3に接続することで、細胞処理装置1において処理された細胞を細胞回収容器100に回収することが可能である。細胞回収容器100は、その底部に設けられた流通口100aを有し、流通口100aを経由して細胞処理装置1によって処理された細胞懸濁液が流入する。細胞処理装置1において処理された細胞懸濁液を細胞回収容器100に回収する場合、細胞回収容器100の流通口100aは、バルブV22を介して第3の流路F3に接続される。バルブV22は、細胞回収容器100に処理済みの細胞懸濁液を流入させる場合に開状態とされ、それ以外の場合には閉状態とされる。 The cell collection container 100 is a container for collecting the cell suspension processed by the cell processing apparatus 1. The form of the cell collection container 100 is not particularly limited, and for example, a glass or stainless steel container or a container having a plastic bag form can be used. As shown in FIG. 1, by connecting the cell collection container 100 to the third flow path F3, it is possible to collect the cells treated in the cell treatment apparatus 1 in the cell collection container 100. The cell collection container 100 has a flow port 100a provided at the bottom thereof, and the cell suspension processed by the cell processing apparatus 1 flows through the flow port 100a. When the cell suspension treated in the cell treatment apparatus 1 is collected in the cell collection container 100, the flow port 100a of the cell collection container 100 is connected to the third flow path F3 via the valve V22. The valve V22 is opened when the treated cell suspension is allowed to flow into the cell collection container 100, and is closed otherwise.

 また、細胞回収容器100に収容された細胞懸濁液を、細胞処理装置1によって処理する場合には、図3に示すように、細胞回収容器100は、細胞供給部10に接続される。この場合、バルブV22は、細胞回収容器100に収容された細胞懸濁液を細胞供給部10に流入させる場合に開状態とされ、それ以外の場合には閉状態とされる。 In addition, when the cell suspension accommodated in the cell collection container 100 is processed by the cell processing apparatus 1, the cell collection container 100 is connected to the cell supply unit 10 as shown in FIG. In this case, the valve V22 is opened when the cell suspension accommodated in the cell collection container 100 is allowed to flow into the cell supply unit 10, and is closed otherwise.

 細胞処理装置1において各流路を構成する配管同士の接続部Xは、滅菌コネクタで構成されていることが好ましい。 In the cell treatment apparatus 1, it is preferable that the connection part X between the pipes constituting each flow path is constituted by a sterilization connector.

 細胞処理装置1において、第1の流路F1を通過する細胞懸濁液の流れ方向は、常に細胞供給部10から濃縮部20に向かう方向(図1に示す矢印の方向)となるように制御されることが好ましい。 In the cell treatment apparatus 1, the flow direction of the cell suspension passing through the first flow path F1 is controlled so as to always be the direction from the cell supply unit 10 toward the concentration unit 20 (the direction of the arrow shown in FIG. 1). It is preferred that

 第1の流路F1を通過する細胞懸濁液の液流は、例えば、第1の流路F1上に配置されたポンプ(図示せず)によって形成してもよい。この場合、第1の流路F1上に配置されたポンプの回転方向によって第1の流路F1を通過する細胞懸濁液の流れ方向を制御することが可能である。 The liquid flow of the cell suspension passing through the first channel F1 may be formed by, for example, a pump (not shown) disposed on the first channel F1. In this case, it is possible to control the flow direction of the cell suspension passing through the first flow path F1 by the rotation direction of the pump arranged on the first flow path F1.

 また、第1の流路F1を通過する細胞懸濁液の液流は、細胞供給部10または培地供給部51の内部の圧力と、貯留容器23Aまたは23Bの内部の圧力との差圧によって形成してもよい。この場合、貯留容器23Aおよび23Bに設けられた加圧装置24A、24Bおよび圧力制御装置25A、25Bと同様の機構が、細胞供給部10および培地供給部51に設けられる。例えば、細胞供給部10の内部の圧力を、貯留容器23Aまたは23Bの内部の圧力よりも高くすることで、第1の流路F1を通過する細胞懸濁液の流れ方向を、細胞供給部10から濃縮部20に向かう方向とすることができる。なお、第1の流路F1を通過する細胞懸濁液の液流を形成する手段としては、細胞供給部10、培地供給部51および貯留容器23A、23Bの内部への圧力印加に限らず、外部から圧力を印加してもよい。 Further, the liquid flow of the cell suspension passing through the first flow path F1 is formed by a differential pressure between the pressure inside the cell supply unit 10 or the medium supply unit 51 and the pressure inside the storage container 23A or 23B. May be. In this case, the same mechanism as the pressurization devices 24A and 24B and the pressure control devices 25A and 25B provided in the storage containers 23A and 23B is provided in the cell supply unit 10 and the culture medium supply unit 51. For example, by making the pressure inside the cell supply unit 10 higher than the pressure inside the storage container 23A or 23B, the flow direction of the cell suspension passing through the first flow path F1 is changed to the cell supply unit 10. The direction toward the concentrating unit 20 can be made. The means for forming the liquid flow of the cell suspension passing through the first flow path F1 is not limited to the application of pressure to the inside of the cell supply unit 10, the medium supply unit 51, and the storage containers 23A and 23B. Pressure may be applied from the outside.

 なお、第1の流路F1において細胞懸濁液の逆流を防止するために、第1の流路F1の下流側の端部にバルブV20を設けてもよい。バルブV20は、第1の流路F1に細胞懸濁液を流す場合に開状態とされ、それ以外の場合には閉状態とされる。なお、第1の流路F1において細胞懸濁液の逆流を防止するための他の手段として逆止弁や逆止防止バルブ等を用いることも可能である。逆止弁や逆止防止バルブを用いることで、第1の流路F1において上流側から下流側に向かう液流を通過させる一方、逆方向の液流を遮断することが可能である。 Note that a valve V20 may be provided at the downstream end of the first flow path F1 in order to prevent the back flow of the cell suspension in the first flow path F1. The valve V20 is opened when the cell suspension is passed through the first flow path F1, and is closed otherwise. Note that a check valve, a check valve or the like can be used as another means for preventing the back flow of the cell suspension in the first flow path F1. By using a check valve or a check valve, the liquid flow from the upstream side to the downstream side can be passed through the first flow path F1, while the liquid flow in the reverse direction can be blocked.

 細胞処理装置1において、第2の流路F2を通過する細胞懸濁液の流れ方向は、常に濃縮部20、撹拌部40またはバイパス流路F20から分割部30またはバイパス流路F10に向かう方向(図1に示す矢印の方向)となるように制御されることが好ましい。 In the cell treatment device 1, the flow direction of the cell suspension passing through the second flow path F2 is always the direction from the concentration unit 20, the stirring unit 40, or the bypass flow channel F20 toward the dividing unit 30 or the bypass flow channel F10 ( It is preferably controlled so that the direction of the arrow shown in FIG.

 第2の流路F2を通過する細胞懸濁液の液流は、例えば、第2の流路F2上に配置されたポンプ(図示せず)によって形成してもよい。この場合、第2の流路F2上に配置されたポンプの回転方向によって第2の流路F2を通過する細胞懸濁液の流れ方向を制御することが可能である。 The liquid flow of the cell suspension passing through the second flow path F2 may be formed by, for example, a pump (not shown) disposed on the second flow path F2. In this case, it is possible to control the flow direction of the cell suspension passing through the second flow path F2 by the rotation direction of the pump disposed on the second flow path F2.

 また、第2の流路F2を通過する細胞懸濁液の液流は、貯留容器23Aまたは23Bの内部の圧力と、細胞回収容器100の内部の圧力との差圧によって形成してもよい。或いは、貯留容器23Aまたは23Bの内部の圧力と、分割部30の内部の圧力との差圧によって形成してもよい。この場合、貯留容器23Aおよび23Bに設けられた加圧装置24A、24Bおよび圧力制御装置25A、25Bと同様の機構が細胞回収容器100または分割部30に設けられる。貯留容器23Aまたは23Bの内部の圧力を、細胞回収容器100または分割部30の内部の圧力よりも高くすることで、第2の流路F2を通過する細胞懸濁液の流れ方向を、濃縮部20、撹拌部40またはバイパス流路F20から分割部30またはバイパス流路F10に向かう方向とすることができる。 Further, the liquid flow of the cell suspension passing through the second flow path F2 may be formed by a differential pressure between the pressure inside the storage container 23A or 23B and the pressure inside the cell collection container 100. Or you may form by the differential pressure | voltage of the pressure inside the storage container 23A or 23B, and the pressure inside the division part 30. FIG. In this case, the cell recovery container 100 or the dividing unit 30 is provided with the same mechanism as the pressurization devices 24A and 24B and the pressure control devices 25A and 25B provided in the storage containers 23A and 23B. By making the pressure inside the storage container 23A or 23B higher than the pressure inside the cell collection container 100 or the dividing unit 30, the flow direction of the cell suspension passing through the second flow path F2 is changed to the concentration unit. 20, It can be set as the direction which goes to the division | segmentation part 30 or the bypass flow path F10 from the stirring part 40 or the bypass flow path F20.

 なお、第2の流路F2において細胞懸濁液の逆流を防止するために、第2の流路F2の上流側の端部にバルブV21を設けてもよい。バルブV21は、第2の流路F2に細胞懸濁液を流す場合に開状態とされ、それ以外の場合には閉状態とされる。なお、第2の流路F2において細胞懸濁液の逆流を防止するための他の手段として逆止弁や逆止防止バルブを用いることも可能である。逆止弁や逆止防止バルブを用いることで、第2の流路F2において上流側から下流側に向かう液流を通過させる一方、逆方向の液流を遮断することが可能である。 In addition, in order to prevent the back flow of the cell suspension in the second flow path F2, a valve V21 may be provided at the upstream end of the second flow path F2. The valve V21 is opened when the cell suspension is passed through the second flow path F2, and is closed otherwise. Note that a check valve or a check valve can be used as another means for preventing the back flow of the cell suspension in the second flow path F2. By using a check valve or a check valve, the liquid flow from the upstream side to the downstream side can be passed through the second flow path F2, while the liquid flow in the reverse direction can be blocked.

 また、細胞処理装置1において、第3の流路F3を通過する細胞懸濁液の流れ方向は、常に分割部30またはバイパス流路F10から細胞回収容器100に向かう方向(図1に示す矢印の方向)となるように制御されることが好ましい。 In the cell treatment device 1, the flow direction of the cell suspension passing through the third flow path F3 is always the direction from the dividing section 30 or the bypass flow path F10 toward the cell collection container 100 (indicated by the arrow shown in FIG. 1). Direction).

 第3の流路F3を通過する細胞懸濁液の液流は、例えば、第3の流路F3上に配置されたポンプ(図示せず)によって形成してもよい。この場合、第3の流路F3上に配置されたポンプの回転方向によって第3の流路F3を通過する細胞懸濁液の流れ方向を制御することが可能である。 The liquid flow of the cell suspension passing through the third flow path F3 may be formed by, for example, a pump (not shown) arranged on the third flow path F3. In this case, it is possible to control the flow direction of the cell suspension passing through the third flow path F3 by the rotation direction of the pump disposed on the third flow path F3.

 また、第3の流路F3を通過する細胞懸濁液の液流は、貯留容器23Aまたは23Bの内部の圧力と、細胞回収容器100の内部の圧力との差圧によって形成してもよい。この場合、貯留容器23Aおよび23Bに設けられた加圧装置24A、24Bおよび圧力制御装置25A、25Bと同様の機構が、細胞回収容器100に設けられる。例えば、貯留容器23Aまたは23Bの内部の圧力を細胞回収容器100の内部の圧力よりも高くすることで、第3の流路F3を通過する細胞懸濁液の流れ方向を、分割部30またはバイパス流路F10から細胞回収容器100に向かう方向とすることができる。 Further, the liquid flow of the cell suspension passing through the third flow path F3 may be formed by a differential pressure between the pressure inside the storage container 23A or 23B and the pressure inside the cell collection container 100. In this case, the cell recovery container 100 is provided with the same mechanism as the pressurization devices 24A and 24B and the pressure control devices 25A and 25B provided in the storage containers 23A and 23B. For example, by making the pressure inside the storage container 23A or 23B higher than the pressure inside the cell collection container 100, the flow direction of the cell suspension passing through the third flow path F3 is changed to the dividing unit 30 or the bypass. The direction can be the direction from the flow path F10 toward the cell collection container 100.

 制御部70は、バルブV1~V21の開閉制御を行う。また、細胞懸濁液の液流を第1の流路F1、第2の流路F2および第3の流路F3上に配置されたポンプ(図示せず)によって形成する場合、制御部70は、各ポンプの動作制御をバルブV1~V21の開閉動作と連動させて行う。また、細胞懸濁液の液流を、細胞供給部10、貯留容器23A、23B、分割部30および細胞回収容器100相互間の差圧によって形成する場合、これらの各ユニットに備えられる圧力調整機構の制御を、バルブV1~V21の開閉動作と連動させて行う。すなわち、制御部70は、細胞処理装置1において実施される各処理において、細胞懸濁液が所定の経路を流れるように送液制御を行う。なお、細胞回収容器100に付随するバルブV22の開閉制御は、制御部70が起こってもよいし、手動で行ってもよい。 The control unit 70 performs opening / closing control of the valves V1 to V21. When the liquid flow of the cell suspension is formed by a pump (not shown) arranged on the first flow path F1, the second flow path F2, and the third flow path F3, the control unit 70 The operation control of each pump is performed in conjunction with the opening / closing operation of the valves V1 to V21. Further, when the liquid flow of the cell suspension is formed by the differential pressure among the cell supply unit 10, the storage containers 23A and 23B, the dividing unit 30, and the cell collection container 100, the pressure adjustment mechanism provided in each of these units Is controlled in conjunction with the opening and closing operations of the valves V1 to V21. That is, the control unit 70 performs liquid feeding control so that the cell suspension flows through a predetermined path in each process performed in the cell processing apparatus 1. Note that the control of the opening and closing of the valve V22 associated with the cell collection container 100 may be performed by the control unit 70 or manually.

 以下に、本例示的実施形態に係る細胞処理装置1において実施される処理の一例を示す。細胞処理装置1は、例えば、以下に例示する分割処理、培地交換処理、濃縮処理を実施することができる。 Hereinafter, an example of processing performed in the cell processing apparatus 1 according to the exemplary embodiment will be described. The cell treatment apparatus 1 can perform, for example, a division process, a medium exchange process, and a concentration process exemplified below.

<分割処理>
 多能性幹細胞の培養においては、細胞を培養することによって生じるスフェアと呼ばれる細胞凝集体のサイズが過大となると、細胞凝集体同士が接着融合し、細胞が分化を開始したり、細胞凝集体の中の細胞が壊死したりするといった問題が生じる。従って、細胞凝集体のサイズが過大となることを防止するために、培養期間中の適切な時期に、細胞凝集体を分割する分割処理が必要となる。細胞処理装置1は、上記の分割処理を、以下のようにして実施する。なお、以下の説明では、分割部30における分割処理が機械的分割処理である場合を例示する。図4は、細胞処理装置1が分割処理を実施する場合における細胞及び培地等の流れを示す図である。なお、図4において、細胞及び培地等の流れと、以下に示す各処理ステップとの対応が示されている。
<Division processing>
In the culture of pluripotent stem cells, when the size of cell aggregates called spheres generated by culturing cells becomes excessive, cell aggregates adhere to each other and cells start to differentiate, Problems arise such as necrosis of the cells inside. Therefore, in order to prevent the size of the cell aggregate from becoming excessive, a dividing process for dividing the cell aggregate is required at an appropriate time during the culture period. The cell processing apparatus 1 performs the above-described division processing as follows. In the following description, a case where the dividing process in the dividing unit 30 is a mechanical dividing process will be exemplified. FIG. 4 is a diagram illustrating a flow of cells, a medium, and the like when the cell processing apparatus 1 performs a division process. FIG. 4 shows the correspondence between the flow of cells and culture medium, etc., and the following processing steps.

 細胞処理装置1において分割処理を実施する場合、分割処理の対象となる細胞凝集体は、細胞供給部10に収容され、細胞供給部10から供給される。 When carrying out the division process in the cell treatment apparatus 1, the cell aggregates to be subjected to the division process are accommodated in the cell supply unit 10 and supplied from the cell supply unit 10.

 ステップS1において、バルブV1、V20、V11、V12およびV5が開状態とされ、ポンプの動作制御、または細胞供給部10と貯留容器23Bとの間の差圧制御によって細胞供給部10に収容された細胞懸濁液が、第1の流路F1、バイパス流路F20を経由して貯留容器23Bに移送される。 In step S1, the valves V1, V20, V11, V12, and V5 are opened, and are accommodated in the cell supply unit 10 by controlling the operation of the pump or controlling the differential pressure between the cell supply unit 10 and the storage container 23B. The cell suspension is transferred to the storage container 23B via the first flow path F1 and the bypass flow path F20.

 ステップS2において、バルブV19が開状態とされる。これにより洗浄液供給部60に収容されている洗浄液が細胞供給部10に流入し、細胞供給部10が洗浄される。これにより、細胞供給部10に残留する細胞(細胞凝集体)が洗浄液の液流によって掻きとられる。 In step S2, the valve V19 is opened. As a result, the cleaning liquid stored in the cleaning liquid supply unit 60 flows into the cell supply unit 10 and the cell supply unit 10 is cleaned. Thereby, the cells (cell aggregates) remaining in the cell supply unit 10 are scraped off by the flow of the cleaning liquid.

 ステップS3において、バルブV1、V20、V11、V12およびV5が開状態とされ、ポンプの動作制御、または細胞供給部10と貯留容器23Bとの間の差圧制御によって細胞供給部10に残留していた細胞(細胞凝集体)および洗浄液が、第1の流路F1、バイパス流路F20を経由して貯留容器23Bに移送される。すなわち、細胞供給部10に残留していた細胞(細胞凝集体)は、ステップS1において貯留容器23Bに移送された細胞(細胞凝集体)とともに貯留容器23Bに貯留される。 In step S3, the valves V1, V20, V11, V12 and V5 are opened and remain in the cell supply unit 10 by controlling the operation of the pump or controlling the differential pressure between the cell supply unit 10 and the storage container 23B. The cells (cell aggregates) and the washing liquid are transferred to the storage container 23B via the first flow path F1 and the bypass flow path F20. That is, the cells (cell aggregates) remaining in the cell supply unit 10 are stored in the storage container 23B together with the cells (cell aggregates) transferred to the storage container 23B in step S1.

 ステップS4において、バルブV5、V3、V2およびV4が開状態とされ、貯留容器23Aと貯留容器23Bとの間の差圧制御により、貯留容器23Bに貯留された細胞(細胞凝集体)、洗浄液および培地を含む細胞懸濁液は、フィルタ部21を経由して貯留容器23Aに移送される。細胞懸濁液は、フィルタ部21を通過する間に濃縮処理が施される。 In step S4, the valves V5, V3, V2, and V4 are opened, and the cells (cell aggregates) stored in the storage container 23B, the washing liquid, and the control are performed by controlling the differential pressure between the storage container 23A and the storage container 23B. The cell suspension containing the medium is transferred to the storage container 23A via the filter unit 21. The cell suspension is concentrated while passing through the filter unit 21.

 フィルタ部21は、流通口21bから流入した細胞(細胞凝集体)、洗浄液および培地を含む細胞懸濁液から洗浄液および培地を除去して細胞の濃度を高める濃縮処理を行う。洗浄液および培地は、濾過液回収容器22に回収され、濃縮された細胞懸濁液は、流通口21aから排出され、貯留容器23Aに貯留される。なお、貯留容器23Aと貯留容器23Bとの間で細胞懸濁液を往復移動させることで、フィルタ部21による濃縮処理を複数回に亘り連続的に実施してもよい。 The filter unit 21 performs a concentration process for removing the washing solution and the medium from the cell suspension containing the cells (cell aggregates), the washing solution and the medium flowing in from the flow port 21b to increase the concentration of the cells. The washing liquid and the culture medium are collected in the filtrate collection container 22, and the concentrated cell suspension is discharged from the circulation port 21a and stored in the storage container 23A. In addition, you may implement the concentration process by the filter part 21 continuously in multiple times by reciprocating a cell suspension between the storage container 23A and the storage container 23B.

 ステップS5において、バルブV19、V1、V20、V11、V12、V5が開状態とされ、ポンプの動作制御、または細胞供給部10と貯留容器23Bとの間の差圧制御によって洗浄液供給部60に収容された洗浄液が細胞供給部10、第1の流路F1、バイパス流路F20を経由して貯留容器23Bに移送される。続いて、バルブV5、V3、V2およびV4が開状態とされ、貯留容器23Aと貯留容器23Bとの間の差圧制御により、貯留容器23Bに貯留された洗浄液は、フィルタ部21に流れる。洗浄液がフィルタ部21に流れることで、フィルタ部21の濾過膜上に残留する細胞(細胞凝集体)が洗浄液の液流によって掻きとられ、ステップS4において貯留容器23Aに移送された細胞(細胞凝集体)とともに貯留容器23Aに貯留される。 In step S5, the valves V19, V1, V20, V11, V12, and V5 are opened and accommodated in the cleaning liquid supply unit 60 by controlling the operation of the pump or controlling the differential pressure between the cell supply unit 10 and the storage container 23B. The washed liquid thus transferred is transferred to the storage container 23B via the cell supply unit 10, the first flow path F1, and the bypass flow path F20. Subsequently, the valves V5, V3, V2, and V4 are opened, and the cleaning liquid stored in the storage container 23B flows to the filter unit 21 by the differential pressure control between the storage container 23A and the storage container 23B. As the washing liquid flows into the filter unit 21, cells (cell aggregates) remaining on the filtration membrane of the filter unit 21 are scraped by the washing liquid flow, and the cells (cell coagulation) transferred to the storage container 23A in step S4. Is collected in the storage container 23A.

 ステップS6において、バルブV17、V20およびV4が開状態とされ、ポンプの動作制御または培地供給部51と貯留容器23Aとの間の差圧制御によって培地供給部51に収容されている新鮮な培地が第1の流路F1を経由して貯留容器23Aに移送される。これにより、貯留容器23Aに貯留されている細胞(細胞凝集体)に、新鮮な培地が供給される。 In step S6, the valves V17, V20, and V4 are opened, and the fresh medium stored in the medium supply unit 51 is controlled by the pump operation control or the differential pressure control between the medium supply unit 51 and the storage container 23A. It is transferred to the storage container 23A via the first flow path F1. Thereby, a fresh culture medium is supplied to the cells (cell aggregates) stored in the storage container 23A.

 ステップS7において、バルブV4、V9、V10、V21、V13、V14およびV22が開状態とされ、ポンプの動作制御または貯留容器23Aと細胞回収容器100との間の差圧制御によって貯留容器23Aに貯留された細胞懸濁液が撹拌部40、第2の流路F2、分割部30および第3の流路F3を経由して細胞回収容器100に移送される。 In step S7, the valves V4, V9, V10, V21, V13, V14, and V22 are opened and stored in the storage container 23A by pump operation control or differential pressure control between the storage container 23A and the cell collection container 100. The cell suspension thus obtained is transferred to the cell collection container 100 via the stirring unit 40, the second channel F2, the dividing unit 30, and the third channel F3.

 細胞懸濁液は、撹拌部40を通過することで撹拌される。これにより、細胞(細胞凝集体)は、培地中に均一に分散する。 The cell suspension is stirred by passing through the stirring unit 40. Thereby, cells (cell aggregates) are uniformly dispersed in the medium.

 撹拌部40を通過した細胞懸濁液は、流入口30aから分割部30の処理容器に流入する。懸濁液に含まれる細胞(細胞凝集体)は、分割部30の処理容器に流入し処理容器に設けられたメッシュフィルタを通過することで、メッシュフィルタのメッシュサイズに応じたサイズに分割される。分割処理が施された細胞(細胞凝集体)を含む細胞懸濁液は、流出口30bから排出され、第3の流路F3を経由して細胞回収容器100に収容される。 The cell suspension that has passed through the stirring unit 40 flows into the processing container of the dividing unit 30 from the inflow port 30a. The cells (cell aggregates) contained in the suspension flow into the processing container of the dividing unit 30 and pass through the mesh filter provided in the processing container, thereby being divided into sizes according to the mesh size of the mesh filter. . The cell suspension containing the cells (cell aggregates) subjected to the division treatment is discharged from the outflow port 30b and is stored in the cell collection container 100 via the third flow path F3.

 ステップS8において、バルブV18およびV22が開状態とされ、ポンプの動作制御、または培地供給部52と細胞回収容器100との間の差圧制御によって培地供給部52に収容されている新鮮な培地が第3の流路F3を経由して細胞回収容器100に移送される。これにより、細胞回収容器100内の培地の量が調整される。なお、培地量の調整が不要な場合には培地供給部52からの培地供給を省略してもよい。 In step S8, the valves V18 and V22 are opened, and the fresh medium stored in the medium supply unit 52 is controlled by the pump operation control or the differential pressure control between the medium supply unit 52 and the cell collection container 100. It is transferred to the cell collection container 100 via the third flow path F3. Thereby, the quantity of the culture medium in the cell collection container 100 is adjusted. If adjustment of the amount of medium is not required, the medium supply from the medium supply unit 52 may be omitted.

 分割処理が完了した後、細胞回収容器100に回収された細胞は、細胞培養容器(図示せず)に移され、細胞培養が継続される。また、分割部30による分割処理が施された細胞(細胞凝集体)を含む細胞懸濁液の全部または一部を保存容器に収容して冷凍保存してもよい。 After the division process is completed, the cells collected in the cell collection container 100 are transferred to a cell culture container (not shown), and the cell culture is continued. Further, all or a part of the cell suspension containing the cells (cell aggregates) subjected to the dividing process by the dividing unit 30 may be stored in a storage container and stored frozen.

<培地交換処理>
 細胞培養においては、細胞から分泌される代謝物などによって培地が変質する。そのため、培養期間中における適切な時期に、使用済みの培地を、新鮮な培地に交換する培地交換処理が必要とされる。細胞処理装置1は、上記の培地交換処理を、以下のようにして実施する。図5は、細胞処理装置1が培地交換処理を実施する場合における細胞および培地等の流れを示す図である。なお、図5において、細胞および培地等の流れと、以下に示す各処理ステップとの対応が示されている。
<Medium medium replacement process>
In cell culture, the medium is altered by metabolites secreted from the cells. For this reason, a medium replacement process is required to replace a used medium with a fresh medium at an appropriate time during the culture period. The cell treatment apparatus 1 performs the above-described medium exchange process as follows. FIG. 5 is a diagram illustrating a flow of cells, a medium, and the like when the cell processing apparatus 1 performs a medium replacement process. FIG. 5 shows the correspondence between the flow of cells and culture medium, etc., and the following processing steps.

 細胞回収容器100に収容されている使用済みの培地を新鮮な培地に交換する場合、図3に示すように、細胞回収容器100を細胞供給部10に接続する。その後、バルブV22を開状態とすることで、細胞回収容器100に収容されている使用済み培地を含む細胞懸濁液を細胞供給部10に投入する。その後、細胞回収容器100は、図1に示すように、第3の流路F3に接続される。 When replacing a used medium stored in the cell collection container 100 with a fresh medium, the cell collection container 100 is connected to the cell supply unit 10 as shown in FIG. Thereafter, by opening the valve V22, the cell suspension containing the used medium contained in the cell collection container 100 is put into the cell supply unit 10. Thereafter, the cell collection container 100 is connected to the third flow path F3 as shown in FIG.

 ステップS11において、バルブV1、V20、V11、V12およびV5が開状態とされ、ポンプの動作制御、または細胞供給部10と貯留容器23Bとの間の差圧制御によって細胞供給部10に収容された使用済み培地を含む細胞懸濁液が、第1の流路F1、バイパス流路F20を経由して貯留容器23Bに移送される。 In step S11, the valves V1, V20, V11, V12, and V5 are opened, and are accommodated in the cell supply unit 10 by pump operation control or differential pressure control between the cell supply unit 10 and the storage container 23B. The cell suspension containing the used medium is transferred to the storage container 23B via the first channel F1 and the bypass channel F20.

 ステップS12において、バルブV19が開状態とされる。これにより洗浄液供給部60に収容されている洗浄液が細胞供給部10に流入し、細胞供給部10が洗浄される。これにより、細胞供給部10に残留する細胞が洗浄液の液流によって掻きとられる。 In step S12, the valve V19 is opened. As a result, the cleaning liquid stored in the cleaning liquid supply unit 60 flows into the cell supply unit 10 and the cell supply unit 10 is cleaned. Thereby, the cells remaining in the cell supply unit 10 are scraped off by the flow of the cleaning liquid.

 ステップS13において、バルブV1、V20、V11、V12およびV5が開状態とされ、ポンプの動作制御、または細胞供給部10と貯留容器23Bとの間の差圧制御によって細胞供給部10に残留していた細胞および洗浄液が、第1の流路F1、バイパス流路F20を経由して貯留容器23Bに移送される。すなわち、細胞供給部10に残留していた細胞は、ステップS11において貯留容器23Bに移送された細胞とともに貯留容器23Bに貯留される。 In step S13, the valves V1, V20, V11, V12, and V5 are opened and remain in the cell supply unit 10 by controlling the operation of the pump or controlling the differential pressure between the cell supply unit 10 and the storage container 23B. The cells and the washing liquid are transferred to the storage container 23B via the first flow path F1 and the bypass flow path F20. That is, the cells remaining in the cell supply unit 10 are stored in the storage container 23B together with the cells transferred to the storage container 23B in step S11.

 ステップS14において、バルブV5、V3、V2およびV4が開状態とされ、貯留容器23Aと貯留容器23Bとの間の差圧制御により、貯留容器23Bに貯留された細胞、洗浄液および使用済み培地を含む細胞懸濁液は、フィルタ部21を経由して貯留容器23Aに移送される。細胞懸濁液は、フィルタ部21を通過する間に濃縮処理が施される。 In step S14, the valves V5, V3, V2, and V4 are opened, and the cells stored in the storage container 23B, the washing solution, and the used medium are included by controlling the differential pressure between the storage container 23A and the storage container 23B. The cell suspension is transferred to the storage container 23A via the filter unit 21. The cell suspension is concentrated while passing through the filter unit 21.

 フィルタ部21は、流通口21bから流入した細胞、洗浄液および使用済み培地を含む細胞懸濁液から洗浄液および使用済み培地を除去して細胞の濃度を高める濃縮処理を行う。洗浄液および使用済みの培地は、濾過液回収容器22に回収され、濃縮された細胞懸濁液は、流通口21aから排出され、貯留容器23Aに貯留される。なお、貯留容器23Aと貯留容器23Bとの間で細胞懸濁液を往復移動させることで、フィルタ部21による濃縮処理を複数回に亘り連続的に実施してもよい。 The filter unit 21 performs a concentration process to remove the washing solution and the used medium from the cell suspension containing the cells, the washing solution, and the used medium that have flowed from the flow port 21b, thereby increasing the cell concentration. The washing liquid and the used culture medium are collected in the filtrate collection container 22, and the concentrated cell suspension is discharged from the circulation port 21a and stored in the storage container 23A. In addition, you may implement the concentration process by the filter part 21 continuously in multiple times by reciprocating a cell suspension between the storage container 23A and the storage container 23B.

 ステップS15において、バルブV1、V20、V11、V12、V5が開状態とされ、ポンプの動作制御、または細胞供給部10と貯留容器23Bとの間の差圧制御によって洗浄液供給部60に収容されている洗浄液が細胞供給部10、第1の流路F1、バイパス流路F20を経由して貯留容器23Bに移送される。続いて、バルブV5、V3、V2およびV4が開状態とされ、貯留容器23Aと貯留容器23Bとの間の差圧制御により、貯留容器23Bに貯留された洗浄液は、フィルタ部21に流れる。洗浄液がフィルタ部21に流れることで、フィルタ部21の濾過膜上に残留する細胞が洗浄液の液流によって掻きとられ、ステップS14において貯留容器23Aに移送された細胞とともに貯留容器23Aに貯留される。 In step S15, the valves V1, V20, V11, V12, and V5 are opened, and are accommodated in the cleaning liquid supply unit 60 by pump operation control or differential pressure control between the cell supply unit 10 and the storage container 23B. The cleaning solution is transferred to the storage container 23B via the cell supply unit 10, the first flow path F1, and the bypass flow path F20. Subsequently, the valves V5, V3, V2, and V4 are opened, and the cleaning liquid stored in the storage container 23B flows to the filter unit 21 by the differential pressure control between the storage container 23A and the storage container 23B. As the cleaning liquid flows through the filter unit 21, the cells remaining on the filtration membrane of the filter unit 21 are scraped off by the liquid flow of the cleaning liquid and stored in the storage container 23A together with the cells transferred to the storage container 23A in step S14. .

 ステップS16において、バルブV17、V20およびV4が開状態とされ、ポンプの動作制御、または培地供給部51と貯留容器23Aとの間の差圧制御によって培地供給部51に収容されている新鮮な培地が第1の流路F1を経由して貯留容器23Aに移送される。これにより、貯留容器23Aに貯留されている細胞に、新鮮な培地が供給される。 In step S16, the valves V17, V20, and V4 are opened, and the fresh medium stored in the medium supply unit 51 by controlling the operation of the pump or controlling the differential pressure between the medium supply unit 51 and the storage container 23A. Is transferred to the storage container 23A via the first flow path F1. Thereby, a fresh culture medium is supplied to the cells stored in the storage container 23A.

 ステップS17において、バルブV4、V9、V10、V21、V15、V16およびV22が開状態とされ、ポンプの動作制御または貯留容器23Aと細胞回収容器100との間の差圧制御によって貯留容器23Aに貯留された細胞懸濁液が撹拌部40、第2の流路F2、バイパス流路F10および第3の流路F3を経由して細胞回収容器100に移送される。 In step S17, the valves V4, V9, V10, V21, V15, V16, and V22 are opened, and stored in the storage container 23A by pump operation control or differential pressure control between the storage container 23A and the cell collection container 100. The cell suspension thus obtained is transferred to the cell collection container 100 via the stirring unit 40, the second flow path F2, the bypass flow path F10, and the third flow path F3.

 細胞懸濁液は、撹拌部40を通過することで撹拌される。これにより、細胞は、培地中に均一に分散する。 The cell suspension is stirred by passing through the stirring unit 40. Thereby, the cells are uniformly dispersed in the medium.

 撹拌部40を通過した細胞懸濁液は、第2の流路F2、バイパス流路F10および第3の流路F3を経由して細胞回収容器100内に収容される。 The cell suspension that has passed through the stirring unit 40 is accommodated in the cell collection container 100 via the second flow path F2, the bypass flow path F10, and the third flow path F3.

 ステップS18において、バルブV18およびV22が開状態とされ、ポンプの動作制御または培地供給部52と細胞回収容器100との間の差圧制御によって培地供給部52に収容されている新鮮な培地が第3の流路F3を経由して細胞回収容器100に移送される。これにより、細胞回収容器100内の培地の量が調整される。なお、培地量の調整が不要な場合には培地供給部52からの培地供給を省略してもよい。 In step S18, the valves V18 and V22 are opened, and the fresh medium contained in the medium supply unit 52 is controlled by controlling the operation of the pump or controlling the differential pressure between the medium supply unit 52 and the cell collection container 100. 3 is transferred to the cell collection container 100 via the flow path F3. Thereby, the quantity of the culture medium in the cell collection container 100 is adjusted. If adjustment of the amount of medium is not required, the medium supply from the medium supply unit 52 may be omitted.

<濃縮処理>
 上記のように、細胞懸濁液の濃縮処理は、分割処理および培地交換処理に伴って実施されるが、本例示的実施形態に係る細胞処理装置1によれば、細胞懸濁液の濃縮処理を単独で実施することも可能である。図6は、細胞処理装置1が濃縮処理を単独で実施する場合における細胞および培地等の流れを示す図である。なお、図6において、細胞および培地等の流れと、以下に示す各処理ステップとの対応が示されている。
<Concentration treatment>
As described above, the cell suspension concentration process is performed along with the division process and the medium exchange process. However, according to the cell processing apparatus 1 according to the exemplary embodiment, the cell suspension concentration process is performed. Can also be carried out alone. FIG. 6 is a diagram illustrating the flow of cells, culture medium, and the like when the cell processing apparatus 1 performs the concentration process alone. FIG. 6 shows the correspondence between the flow of cells and culture medium and the following processing steps.

 細胞回収容器100内の細胞懸濁液を濃縮する場合、図3に示すように、細胞回収容器100を細胞供給部10に接続する。その後、バルブV22を開状態とすることで、細胞回収容器100内に収容されている細胞および培地を含む細胞懸濁液を細胞供給部10に投入する。その後、細胞回収容器100は、図1に示すように、第3の流路F3に接続される。なお、細胞回収容器100内の細胞懸濁液以外を対象として濃縮処理を行うことも可能である。 When the cell suspension in the cell collection container 100 is concentrated, the cell collection container 100 is connected to the cell supply unit 10 as shown in FIG. Thereafter, by opening the valve V22, the cell suspension containing the cells and the medium contained in the cell collection container 100 is put into the cell supply unit 10. Thereafter, the cell collection container 100 is connected to the third flow path F3 as shown in FIG. In addition, it is also possible to perform a concentration process for objects other than the cell suspension in the cell collection container 100.

 ステップS31において、バルブV1、V20およびV4が開状態とされ、ポンプの動作制御または細胞供給部10と貯留容器23Aとの間の差圧制御によって細胞供給部10に収容された細胞懸濁液が、第1の流路F1を経由して貯留容器23Aに移送される。 In step S31, the valves V1, V20, and V4 are opened, and the cell suspension accommodated in the cell supply unit 10 is controlled by pump operation control or differential pressure control between the cell supply unit 10 and the storage container 23A. Then, it is transferred to the storage container 23A via the first flow path F1.

 ステップS32において、バルブV19が開状態とされる。これにより洗浄液供給部60に収容されている洗浄液が細胞供給部10に流入し、細胞供給部10が洗浄される。これにより、細胞供給部10に残留する細胞が洗浄液の液流によって掻きとられる。 In step S32, the valve V19 is opened. As a result, the cleaning liquid stored in the cleaning liquid supply unit 60 flows into the cell supply unit 10 and the cell supply unit 10 is cleaned. Thereby, the cells remaining in the cell supply unit 10 are scraped off by the flow of the cleaning liquid.

 ステップS33において、バルブV1、V20およびV4が開状態とされ、ポンプの動作制御、または細胞供給部10と貯留容器23Aとの間の差圧制御によって細胞供給部10に残留していた細胞および洗浄液が、第1の流路F1を経由して貯留容器23Aに移送される。すなわち、細胞供給部10に残留していた細胞は、ステップS31において貯留容器23Aに移送された細胞とともに貯留容器23Aに貯留される。 In step S33, the valves V1, V20 and V4 are opened, and the cells and washing liquid remaining in the cell supply unit 10 by controlling the operation of the pump or controlling the differential pressure between the cell supply unit 10 and the storage container 23A. Is transferred to the storage container 23A via the first flow path F1. That is, the cells remaining in the cell supply unit 10 are stored in the storage container 23A together with the cells transferred to the storage container 23A in step S31.

 ステップS34において、バルブV4、V2、V3、V21、V15、V16およびV22が開状態とされ、ポンプの動作制御または貯留容器23Aと細胞回収容器100との間の差圧制御によって貯留容器23Aに貯留された細胞、洗浄液および培地を含む細胞懸濁液は、フィルタ部21、第2の流路F2、バイパス流路F10、第3の流路F3を経由して細胞回収容器100内に移送される。細胞懸濁液は、フィルタ部21を通過する間に濃縮処理が施される。 In step S34, the valves V4, V2, V3, V21, V15, V16, and V22 are opened and stored in the storage container 23A by pump operation control or differential pressure control between the storage container 23A and the cell collection container 100. The cell suspension containing the cells, the washing solution, and the culture medium is transferred into the cell collection container 100 via the filter unit 21, the second channel F2, the bypass channel F10, and the third channel F3. . The cell suspension is concentrated while passing through the filter unit 21.

 フィルタ部21は、流通口21aから流入した細胞、洗浄液および培地を含む細胞懸濁液から洗浄液、培地および細胞凝集体から離脱してシングルセル化した死細胞等のデブリスを除去して細胞の濃度を高める濃縮処理を行う。洗浄液、培地およびデブリスは、濾過液回収容器22に回収され、濃縮された細胞懸濁液は、流通口21bから排出され、第2の流路F2、バイパス流路F10および第3の流路F3を経由して細胞回収容器100に収容される。なお、貯留容器23Aと貯留容器23Bとの間で細胞懸濁液を往復移動させることで、フィルタ部21による濃縮処理を複数回に亘り連続的に実施してもよい。 The filter unit 21 removes debris such as dead cells that have been detached from the washing solution, the medium, and the cell aggregate from the cell suspension containing the cells, the washing solution, and the medium that have flowed in from the flow port 21a, thereby forming a single cell concentration. To increase the concentration. The washing liquid, the medium, and the debris are collected in the filtrate collection container 22, and the concentrated cell suspension is discharged from the circulation port 21b, and the second flow path F2, the bypass flow path F10, and the third flow path F3. To be accommodated in the cell collection container 100. In addition, you may implement the concentration process by the filter part 21 continuously in multiple times by reciprocating a cell suspension between the storage container 23A and the storage container 23B.

 ステップS35において、バルブV19、V1、V20、V2、V3、V21、V15、V16およびV22が開状態とされ、ポンプの動作制御または細胞供給部10と細胞回収容器100との間の差圧制御によって洗浄液供給部60に収容された洗浄液が細胞供給部10、第1の流路F1、フィルタ部21、第2の流路F2、バイパス流路F10、第3の流路F3を経由して細胞回収容器100に移送される。洗浄液がフィルタ部21に流れることで、フィルタ部21の濾過膜上に残留する細胞が洗浄液の液流によって掻きとられ、ステップS34において細胞回収容器100に収容された細胞とともに細胞回収容器100に収容される。 In step S35, the valves V19, V1, V20, V2, V3, V21, V15, V16, and V22 are opened, and pump pressure control or differential pressure control between the cell supply unit 10 and the cell collection container 100 is performed. The cleaning liquid stored in the cleaning liquid supply unit 60 is recovered through the cell supply unit 10, the first channel F1, the filter unit 21, the second channel F2, the bypass channel F10, and the third channel F3. It is transferred to the container 100. As the washing liquid flows into the filter unit 21, cells remaining on the filtration membrane of the filter unit 21 are scraped off by the washing liquid flow, and are accommodated in the cell collection container 100 together with the cells contained in the cell collection container 100 in step S34. Is done.

 ステップS36において、バルブV18およびV22が開状態とされ、ポンプの動作制御または培地供給部52と細胞回収容器100との間の差圧制御によって培地供給部52に収容されている新鮮な培地が第3の流路F3を経由して細胞回収容器100に移送される。これにより、細胞回収容器100内の培地の量が調整される。なお、培地量の調整が不要な場合には培地供給部52からの培地供給を省略してもよい。 In step S36, the valves V18 and V22 are opened, and the fresh medium contained in the medium supply unit 52 is controlled by the pump operation control or the differential pressure control between the medium supply unit 52 and the cell collection container 100. 3 is transferred to the cell collection container 100 via the flow path F3. Thereby, the quantity of the culture medium in the cell collection container 100 is adjusted. If adjustment of the amount of medium is not required, the medium supply from the medium supply unit 52 may be omitted.

 以上の説明から明らかなように、本発明の例示的実施形態に係る細胞処理装置1において、濃縮部20は、細胞供給部10の下流側に設けられ、第1の流路F1を介して細胞供給部10に接続されている。また、分割部30は、濃縮部20の下流側に設けられ、第2の流路F2を介して濃縮部20に接続されている。すなわち、細胞処理装置1において、細胞供給部10、濃縮部20および分割部30は、この順で直列接続されて構成されている。また、図1に示すように、第3の流路F3に細胞回収容器100を接続した場合には、細胞供給部10、濃縮部20、分割部30および細胞回収容器100がこの順で直列接続された構成となる。また、細胞処理装置1において、第1の流路F1、第2の流路F2および第3の流路F3を通過する細胞懸濁液の流れ方向は、一方向のみとされる。すなわち、第1の流路F1、第2の流路F2および第3の流路F3は一方通行流路とされる。このように、細胞処理装置1において細胞供給部10、濃縮部20および分割部30を一方通行流路を介して直列に接続することで、分割処理前後の細胞が混ざり合うコンタミネーションのリスクを低減することが可能となる。 As is clear from the above description, in the cell processing apparatus 1 according to the exemplary embodiment of the present invention, the concentration unit 20 is provided on the downstream side of the cell supply unit 10, and the cells are passed through the first flow path F1. It is connected to the supply unit 10. The dividing unit 30 is provided on the downstream side of the concentration unit 20 and is connected to the concentration unit 20 via the second flow path F2. That is, in the cell treatment apparatus 1, the cell supply unit 10, the concentration unit 20, and the division unit 30 are configured to be connected in series in this order. As shown in FIG. 1, when the cell collection container 100 is connected to the third flow path F3, the cell supply unit 10, the concentration unit 20, the dividing unit 30, and the cell collection container 100 are connected in series in this order. It becomes the composition which was done. Moreover, in the cell treatment apparatus 1, the flow direction of the cell suspension passing through the first flow path F1, the second flow path F2, and the third flow path F3 is only one direction. That is, the first flow path F1, the second flow path F2, and the third flow path F3 are one-way flow paths. Thus, by connecting the cell supply unit 10, the concentration unit 20, and the dividing unit 30 in series via the one-way flow path in the cell processing apparatus 1, the risk of contamination in which cells before and after the dividing process are mixed is reduced. It becomes possible to do.

 例えば、分割処理が実施される場合、バイパス流路F10は遮断され、分割部30を経由した細胞のみが細胞回収容器100に回収される。換言すれば、分割処理が実施される場合、細胞は、分割部30を経由することなく細胞回収容器100に回収されることはない。従って、分割処理前の細胞と分割処理後の細胞が混ざり合うコンタミネーションの発生が防止される。 For example, when the division process is performed, the bypass flow path F10 is blocked, and only the cells that have passed through the division unit 30 are collected in the cell collection container 100. In other words, when the division process is performed, the cells are not collected in the cell collection container 100 without passing through the division unit 30. Therefore, it is possible to prevent the occurrence of contamination in which the cells before the division process and the cells after the division process are mixed.

 また、本発明の例示的実施形態に係る細胞処理装置1によれば、細胞供給部10から供給された細胞が、細胞回収容器100に回収されるまでの間に、上記の分割処理、培地交換処理および濃縮処理のいずれか1つが実施される。すなわち、上記の分割処理、培地交換処理および濃縮処理は、互いに独立して実施される。従って、各処理の終了後、細胞回収容器100を細胞処理装置1から取り外し、細胞処理装置1を構成する各処理ユニットおよび各流路を構成する配管を洗浄することが可能である。このように、各処理を分断して実施する装置構成とすることで、循環流路を用いて各処理を連続的に実施する装置構成と比較して、分割処理前後の細胞が混ざり合うコンタミネーションのリスクを低減することができる。 Moreover, according to the cell processing apparatus 1 which concerns on exemplary embodiment of this invention, before the cell supplied from the cell supply part 10 is collect | recovered by the cell collection container 100, said division | segmentation process and culture medium replacement | exchange are performed. Either one of the treatment and the concentration treatment is performed. That is, the above division process, medium exchange process, and concentration process are performed independently of each other. Therefore, after completion of each treatment, the cell collection container 100 can be detached from the cell treatment apparatus 1 and the treatment units constituting the cell treatment apparatus 1 and the pipes constituting each flow path can be washed. In this way, by configuring the device to divide and implement each treatment, contamination in which cells before and after the division treatment are mixed as compared to a device configuration that continuously performs each treatment using a circulation channel. Risk can be reduced.

 また、本発明の例示的実施形態に係る細胞処理装置1において、第2の流路F2と第3の流路F3との間には分割部30およびバイパス流路F10が並列に配置されている。これにより、培地交換処理や濃縮処理を行う場合に、処理済みの細胞懸濁液を、分割部30を経由することなく細胞回収容器100に回収することができる。 In the cell treatment device 1 according to the exemplary embodiment of the present invention, the dividing unit 30 and the bypass channel F10 are arranged in parallel between the second channel F2 and the third channel F3. . Thereby, when performing culture medium exchange processing or concentration processing, the processed cell suspension can be collected in the cell collection container 100 without going through the dividing unit 30.

 また、本発明の例示的実施形態に係る細胞処理装置1において、第1の流路F1と第2の流路F2との間にはフィルタ部21、撹拌部40およびバイパス流路F20が並列に配置されている。また、細胞処理装置1は、第1の流路F1に接続された貯留容器23Aと、第2の流路F2に接続された貯留容器23Bとを含み、貯留容器23Aと貯留容器23Bとの間で相互に細胞懸濁液の移送が可能とされている。この構成によれば、フィルタ部21、撹拌部40およびバイパス流路F20を双方向流路として使用することができ、例えば、フィルタ部21における濃縮処理を複数回に亘り連続して行うことが可能となる。また、例えば、フィルタ部21における濃縮処理と、撹拌部40における撹拌処理を連続的に行うことも可能である。さらに、貯留容器23Aと貯留容器23Bとの間での細胞懸濁液の相互移送を、バイパス流路F20を介して行うことも可能であり、細胞供給部10から供給される細胞懸濁液を、バイパス流路F20を経由して貯留容器23Bに移送することも可能である。 In the cell treatment device 1 according to the exemplary embodiment of the present invention, the filter unit 21, the stirring unit 40, and the bypass channel F20 are arranged in parallel between the first channel F1 and the second channel F2. Has been placed. The cell treatment device 1 includes a storage container 23A connected to the first flow path F1 and a storage container 23B connected to the second flow path F2, and between the storage container 23A and the storage container 23B. Thus, the cell suspension can be transferred to each other. According to this structure, the filter part 21, the stirring part 40, and the bypass flow path F20 can be used as a bidirectional | two-way flow path, for example, the concentration process in the filter part 21 can be performed continuously several times. It becomes. Further, for example, the concentration process in the filter unit 21 and the stirring process in the stirring unit 40 can be continuously performed. Furthermore, the mutual transfer of the cell suspension between the storage container 23A and the storage container 23B can be performed via the bypass channel F20, and the cell suspension supplied from the cell supply unit 10 It is also possible to transfer to the storage container 23B via the bypass flow path F20.

 また、本発明の例示的実施形態に係る細胞処理装置1において、貯留容器23Aは、その底部に設けられた流通口23aを介して細胞懸濁液を流入および流出させる。同様に、貯留容器23Bは、その底部に設けられた流通口23bを介して細胞懸濁液を流入および流出させる。このように、流通口23aおよび23bが、流入口の役割と流出口の役割を兼ねることにより、貯留容器23Aおよび23Bに接続される配管を1つとすることができる。これにより、貯留容器23Aおよび23Bが流入口および流出口を別々に備える場合と比較して配管の数を減らすことができ、細胞が配管に付着することによる細胞のロスを低減することができる。 In addition, in the cell processing apparatus 1 according to the exemplary embodiment of the present invention, the storage container 23A allows the cell suspension to flow in and out through the flow port 23a provided at the bottom thereof. Similarly, the storage container 23B allows the cell suspension to flow in and out through the circulation port 23b provided at the bottom. In this way, the circulation ports 23a and 23b serve as the inflow port and the outflow port, so that one pipe can be connected to the storage containers 23A and 23B. Thereby, compared with the case where storage container 23A and 23B are provided with an inflow port and an outflow port separately, the number of piping can be reduced and the loss of the cell by a cell adhering to piping can be reduced.

 また、流通口23aおよび23bをそれぞれ貯留容器23Aおよび23Bの底部に設けることで、貯留容器23Aおよび23Bに細胞懸濁液を流入させる際に細胞に与えるダメージを抑制することができる。すなわち、流通口23aおよび23bをそれぞれ貯留容器23Aおよび23Bの底部に設けることで、貯留容器23Aおよび23Bの底部にすでに溜まっている細胞懸濁液中に細胞懸濁液が注入される態様で貯留容器23Aおよび23Bに細胞懸濁液を流入させることができる。これにより、細胞懸濁液を貯留容器の上部から落下させる態様で貯留容器23Aおよび23Bに細胞懸濁液を流入させる場合と比較して、細胞へのダメージを軽減でき、細胞のロスを低減することができる。 Further, by providing the circulation ports 23a and 23b at the bottoms of the storage containers 23A and 23B, respectively, damage to the cells when the cell suspension is allowed to flow into the storage containers 23A and 23B can be suppressed. In other words, by providing the flow ports 23a and 23b at the bottoms of the storage containers 23A and 23B, respectively, the cell suspension is stored in such a manner that the cell suspension is injected into the cell suspension already accumulated at the bottoms of the storage containers 23A and 23B. Cell suspension can be flowed into containers 23A and 23B. Thereby, compared with the case where a cell suspension is made to flow into storage container 23A and 23B in the aspect which drops a cell suspension from the upper part of a storage container, the damage to a cell can be reduced and the loss of a cell is reduced. be able to.

 また、本発明の例示的実施形態に係る細胞処理装置1は、第1の流路F1に接続された培地供給部51を有する。これにより、使用済みの培地を新鮮な培地に交換する培地交換処理が可能となる。また、本発明の例示的実施形態に係る細胞処理装置1は、第3の流路F3に接続された培地供給部52を有する。これにより、細胞回収容器100に回収された処理済みの細胞懸濁液に培地を追加することができ、細胞処理装置1において実施される各処理の後に培地量を調整することが可能となる。 In addition, the cell treatment device 1 according to the exemplary embodiment of the present invention includes a medium supply unit 51 connected to the first flow path F1. Thereby, the culture medium exchange process which replaces a used culture medium with a fresh culture medium is attained. Moreover, the cell processing apparatus 1 which concerns on exemplary embodiment of this invention has the culture medium supply part 52 connected to the 3rd flow path F3. Thereby, a culture medium can be added to the treated cell suspension recovered in the cell recovery container 100, and the amount of the culture medium can be adjusted after each process performed in the cell processing apparatus 1.

 また、本発明の例示的実施形態に係る細胞処理装置1は、細胞供給部10に接続された洗浄液供給部60を有する。これにより、処理中に、細胞供給部10およびフィルタ部21等の洗浄を行うことができ、細胞供給部10およびフィルタ部21等に残留する細胞を回収することができる。これにより細胞のロスを低減することができる。 In addition, the cell processing apparatus 1 according to the exemplary embodiment of the present invention includes a cleaning liquid supply unit 60 connected to the cell supply unit 10. Thereby, washing | cleaning of the cell supply part 10, the filter part 21, etc. can be performed during a process, and the cells which remain | survive in the cell supply part 10, the filter part 21, etc. can be collect | recovered. Thereby, the loss of cells can be reduced.

 なお、上記した例示的実施形態においては、細胞回収容器100を細胞処理装置1に取り付けて使用する形態を例示したが、細胞回収容器100が第3の流路F3に取り付けられた形態を細胞処理装置の一形態とみなすことも可能である。 In the above-described exemplary embodiment, the mode in which the cell collection container 100 is attached to the cell processing apparatus 1 is exemplified. However, the mode in which the cell collection container 100 is attached to the third flow path F3 is used as the cell processing. It can also be regarded as a form of the device.

[第2の例示的実施形態]
 図7および図8は、本発明の第2の例示的実施形態に係る細胞処理装置の部分的な構成を示す図である。細胞処理装置は、複数のフィルタ部を備えていてもよく、例えば、図7に示すように、第1の流路F1と第2の流路F2との間に、フィルタ部21Aおよびフィルタ部21Bを並列に配置してもよい。この構成によれば、フィルタ部21Aおよび21Bにおいて並行して濃縮処理を実施することが可能となり、濃縮処理を効率的に実施することが可能となる。
[Second exemplary embodiment]
7 and 8 are views showing a partial configuration of the cell processing apparatus according to the second exemplary embodiment of the present invention. The cell treatment apparatus may include a plurality of filter units. For example, as shown in FIG. 7, the filter unit 21A and the filter unit 21B are provided between the first channel F1 and the second channel F2. May be arranged in parallel. According to this configuration, the concentration process can be performed in parallel in the filter units 21A and 21B, and the concentration process can be performed efficiently.

 また、図8に示すように、第1の流路F1と第2の流路F2との間に、フィルタ部21Aおよびフィルタ部21Bを直列に配置してもよい。この構成によれば、1回の送液でフィルタ部21Aによる濃縮処理とフィルタ部21Bによる濃縮処理を連続して行うことが可能となる。 Further, as shown in FIG. 8, the filter part 21A and the filter part 21B may be arranged in series between the first flow path F1 and the second flow path F2. According to this configuration, it is possible to continuously perform the concentration process by the filter unit 21A and the concentration process by the filter unit 21B with a single liquid feeding.

 図7および図8に示す構成において、フィルタ部21Aおよび21Bにおける濾過方式は、互いに異なる方式であってもよい。例えば、フィルタ部21Aは、タンジェンシャルフロー方式による濾過を行う濾過装置であり、フィルタ部21Bは、遠心力を利用した分離を行う濾過装置であってもよい。また、フィルタ部21Aおよび21Bにおける濾過方式は、互いに同じ方式であってもよい。 7 and FIG. 8, the filtering methods in the filter units 21A and 21B may be different from each other. For example, the filter unit 21A may be a filtration device that performs filtration by a tangential flow method, and the filter unit 21B may be a filtration device that performs separation using centrifugal force. Further, the filtering methods in the filter units 21A and 21B may be the same as each other.

[第3の例示的実施形態]
 図1に示す第1の細胞処理装置1の各構成要素は、細胞培養プロトコル等に応じて適宜省略することが可能である。図9は、第1の例示的実施形態に係る細胞処理装置1の構成を簡略化した、本発明の第3の例示的実施形態に係る細胞処理装置1Aの構成を示す図である。
[Third exemplary embodiment]
Each component of the 1st cell processing apparatus 1 shown in FIG. 1 can be suitably abbreviate | omitted according to a cell culture protocol. FIG. 9 is a diagram showing a configuration of a cell processing apparatus 1A according to the third exemplary embodiment of the present invention, in which the configuration of the cell processing apparatus 1 according to the first exemplary embodiment is simplified.

 細胞処理装置1Aは、第1の例示的実施形態に係る細胞処理装置1から撹拌部40、洗浄液供給部60および培地供給部52を削除した構成に相当する。このように、構成を簡略化することで、細胞処理装置の省スペース化を図ることができる。構成が簡略化された細胞処理装置1Aにおいても、第1の例示的実施形態に係る細胞処理装置1と同様の分割処理、培地交換処理、濃縮処理を実施することが可能である。 The cell treatment apparatus 1A corresponds to a configuration in which the agitation unit 40, the cleaning liquid supply unit 60, and the culture medium supply unit 52 are omitted from the cell treatment apparatus 1 according to the first exemplary embodiment. Thus, by simplifying the configuration, it is possible to save the space of the cell processing apparatus. Even in the cell processing apparatus 1A having a simplified configuration, it is possible to perform the same division process, medium replacement process, and concentration process as those of the cell processing apparatus 1 according to the first exemplary embodiment.

 なお、細胞処理装置1および1A本開示の技術における細胞処理装置の一例である。細胞供給部10は、本開示の技術における細胞供給部の一例である。濃縮部20は、本開示の技術における濃縮部の一例である。分割部30は、本開示の技術における分割部の一例である。第1の流路F1は本開示の技術における第1の流路の一例である。第2の流路F2は本開示の技術における第2の流路の一例である。第3の流路F3は本開示の技術における第3の流路の一例である。フィルタ部21は本開示の技術におけるフィルタ部の一例である。細胞回収容器100は本開示の技術における細胞回収の一例である。バイパス流路F10は、本開示の技術における第1のバイパス流路の一例である。バイパス流路F20は、本開示の技術における第2のバイパス流路の一例である。貯留容器23Aは、本開示の技術における第1の貯留容器の一例である。貯留容器23Bは、本開示の技術における第2の貯留容器の一例である。流通口23aは、本開示の技術における第1の流通口の一例である。流通口23bは、本開示の技術における第2の流通口の一例である。撹拌部40は、本開示の技術における撹拌部の一例である。加圧装置24Aおよび圧力制御装置25Aは、本開示の技術における第1の圧力制御部の一例である。加圧装置24Bおよび圧力制御装置25Bは、本開示の技術における第2の圧力制御部の一例である。培地供給部51は、本開示の技術における第1の培地供給部の一例である。培地供給部52は、本開示の技術における第2の培地供給部の一例である。洗浄液供給部60は、本開示の技術における洗浄液供給部の一例である。 The cell processing apparatus 1 and 1A are examples of the cell processing apparatus in the technology of the present disclosure. The cell supply unit 10 is an example of a cell supply unit in the technology of the present disclosure. The concentration unit 20 is an example of a concentration unit in the technology of the present disclosure. The dividing unit 30 is an example of a dividing unit in the technology of the present disclosure. The first flow path F1 is an example of the first flow path in the technology of the present disclosure. The second flow path F2 is an example of a second flow path in the technology of the present disclosure. The third flow path F3 is an example of a third flow path in the technology of the present disclosure. The filter unit 21 is an example of a filter unit in the technology of the present disclosure. The cell collection container 100 is an example of cell collection in the technology of the present disclosure. The bypass channel F10 is an example of a first bypass channel in the technology of the present disclosure. The bypass channel F20 is an example of a second bypass channel in the technology of the present disclosure. The storage container 23A is an example of a first storage container in the technology of the present disclosure. The storage container 23B is an example of a second storage container in the technology of the present disclosure. The distribution port 23a is an example of a first distribution port in the technology of the present disclosure. The distribution port 23b is an example of a second distribution port in the technology of the present disclosure. The stirring unit 40 is an example of a stirring unit in the technology of the present disclosure. Pressurization device 24A and pressure control device 25A are examples of the 1st pressure control part in the art of this indication. The pressurizing device 24B and the pressure control device 25B are an example of a second pressure control unit in the technology of the present disclosure. The culture medium supply unit 51 is an example of a first culture medium supply unit in the technology of the present disclosure. The culture medium supply unit 52 is an example of a second culture medium supply unit in the technology of the present disclosure. The cleaning liquid supply unit 60 is an example of a cleaning liquid supply unit in the technology of the present disclosure.

 日本出願2016-150671の開示は、その全体が参照により本明細書に取り込まれる。 The entire disclosure of Japanese Application 2016-150671 is incorporated herein by reference.

 本明細書に記載された全ての文献、特許出願、および技術規格は、個々の文献、特許出願、および技術規格が参照により取り込まれることが具体的かつ個々に記された場合と同程度に、本明細書中に参照により取り込まれる。 All documents, patent applications, and technical standards mentioned in this specification are to the same extent as if each individual document, patent application, and technical standard were specifically and individually described to be incorporated by reference, Incorporated herein by reference.

Claims (19)

 細胞を供給する細胞供給部と、
 前記細胞供給部の下流側に設けられて第1の流路を介して前記細胞供給部に接続され、前記細胞および前記細胞に随伴する液体を含む細胞懸濁液から前記液体を除去する濃縮処理を行う濃縮部と、
 前記濃縮部の下流側に設けられて第2の流路を介して前記濃縮部に接続され、前記細胞の凝集体を分割する分割処理を行う分割部と、
 を含む細胞処理装置。
A cell supply section for supplying cells;
A concentration process that is provided on the downstream side of the cell supply unit and is connected to the cell supply unit via a first flow path, and removes the liquid from the cell suspension containing the cells and the liquid accompanying the cells. A concentration unit for performing
A dividing unit that is provided on the downstream side of the concentrating unit and connected to the concentrating unit via a second flow path, and performs a dividing process of dividing the aggregate of the cells;
A cell processing apparatus comprising:
 前記第1の流路は、前記第1の流路を通過する細胞懸濁液が前記細胞供給部側から前記濃縮部側に向けて流れる一方通行の流路であり、
 前記第2の流路は、前記第2の流路を通過する細胞懸濁液が前記濃縮部側から前記分割部側に向けて流れる一方通行の流路である
 請求項1に記載の細胞処理装置。
The first flow channel is a one-way flow channel in which a cell suspension passing through the first flow channel flows from the cell supply unit side toward the concentration unit side,
The cell treatment according to claim 1, wherein the second flow path is a one-way flow path in which a cell suspension passing through the second flow path flows from the concentration section side toward the division section side. apparatus.
 前記濃縮部は、一方の流通口が前記第1の流路に接続され、他方の流通口が前記第2の流路に接続され、前記一方の流通口または前記他方の流通口から流入する細胞懸濁液に対して前記濃縮処理を施して、前記一方の流通口および前記他方の流通口のうち細胞懸濁液が流入した流通口とは異なる流通口から前記濃縮処理を施した細胞懸濁液を排出するフィルタ部を含む、請求項2に記載の細胞処理装置。 The concentrating unit has one flow port connected to the first flow channel, the other flow port connected to the second flow channel, and cells flowing from the one flow port or the other flow port. The cell suspension that has been subjected to the concentration treatment from a flow port different from the flow port into which the cell suspension has flowed out of the one flow port and the other flow port, by performing the concentration treatment on the suspension The cell processing apparatus according to claim 2, further comprising a filter unit that discharges the liquid.  前記分割部は、分割処理を施した細胞を排出する排出口を含み、
 前記排出口に接続された第3の流路と、
 前記第3の流路に接続された細胞回収容器と、
 を更に含む、請求項3に記載の細胞処理装置。
The dividing unit includes a discharge port for discharging cells subjected to the dividing process,
A third flow path connected to the outlet;
A cell collection container connected to the third flow path;
The cell treatment apparatus according to claim 3, further comprising:
 一端が前記第2の流路に接続され、他端が前記第3の流路に接続された第1のバイパス流路を更に含む、請求項4に記載の細胞処理装置。 5. The cell treatment device according to claim 4, further comprising a first bypass channel having one end connected to the second channel and the other end connected to the third channel.  前記濃縮部は、前記第1の流路に接続された第1の貯留容器と、前記第2の流路に接続された第2の貯留容器と、を更に含む、請求項3から請求項5のいずれか1項に記載の細胞処理装置。 The said concentration part further contains the 1st storage container connected to the said 1st flow path, and the 2nd storage container connected to the said 2nd flow path. The cell treatment apparatus according to any one of the above.  一方の端部が前記第1の流路に接続され、他方の端部が前記第2の流路に接続され、前記一方の端部または前記他方の端部から流入する細胞懸濁液に対して撹拌処理を施して、前記一方の端部および前記他方の端部のうち細胞懸濁液が流入した端部とは異なる端部から前記撹拌処理を施した細胞懸濁液を排出する撹拌部を更に含む、請求項3から請求項6のいずれか1項に記載の細胞処理装置。 One end is connected to the first flow path, the other end is connected to the second flow path, and the cell suspension flows from the one end or the other end. The agitation unit that performs the agitation process and discharges the cell suspension subjected to the agitation process from an end part of the one end part and the other end part different from the end part into which the cell suspension has flowed The cell treatment device according to any one of claims 3 to 6, further comprising:  一端が前記第1の流路に接続され、他端が前記第2の流路に接続された第2のバイパス流路を更に含む、請求項3から請求項7のいずれか1項に記載の細胞処理装置。 8. The method according to claim 3, further comprising a second bypass flow path having one end connected to the first flow path and the other end connected to the second flow path. Cell processing equipment.  前記第1の貯留容器は、前記第1の流路に接続された第1の流通口を介して細胞懸濁液を流入および流出させ、
 前記第2の貯留容器は、前記第2の流路に接続された第2の流通口を介して細胞懸濁液を流入および流出させる
 請求項6に記載の細胞処理装置。
The first storage container allows the cell suspension to flow in and out through the first flow port connected to the first flow path,
The cell processing apparatus according to claim 6, wherein the second storage container allows a cell suspension to flow in and out through a second circulation port connected to the second flow path.
 前記第1の流通口は、前記第1の貯留容器の底部に設けられ、
 前記第2の流通口は、前記第2の貯留容器の底部に設けられている
 請求項9に記載の細胞処理装置。
The first circulation port is provided at the bottom of the first storage container,
The cell processing apparatus according to claim 9, wherein the second circulation port is provided at a bottom portion of the second storage container.
 前記第1の貯留容器の内部の圧力を制御する第1の圧力制御部と、
 前記第2の貯留容器の内部の圧力を制御する第2の圧力制御部と、
 を更に含む、請求項6、請求項9および請求項10のいずれか1項に記載の細胞処理装置。
A first pressure control unit for controlling the pressure inside the first storage container;
A second pressure control unit for controlling the pressure inside the second storage container;
The cell treatment apparatus according to any one of claims 6, 9, and 10, further comprising:
 前記濃縮部は、前記第1の流路と前記第2の流路との間に、互いに直列または並列に配置された前記フィルタ部を含む複数のフィルタ部を含む、請求項3から請求項11のいずれか1項に記載の細胞処理装置。 The said concentration part contains the several filter part containing the said filter part arrange | positioned mutually in series or in parallel between the said 1st flow path and the said 2nd flow path. The cell treatment apparatus according to any one of the above.  前記フィルタ部は、タンジェンシャルフロー方式による濾過を行う、請求項3から請求項12のいずれか1項に記載の細胞処理装置。 The cell processing apparatus according to any one of claims 3 to 12, wherein the filter unit performs filtration by a tangential flow method.  前記フィルタ部は、遠心力を利用した分離を行う、請求項3から請求項12のいずれか1項に記載の細胞処理装置。 The cell processing apparatus according to any one of claims 3 to 12, wherein the filter unit performs separation using centrifugal force.  前記複数のフィルタ部は、タンジェンシャルフロー方式による濾過を行う第1のフィルタ部と、遠心力を利用した分離を行う第2のフィルタ部と、を含む、請求項12に記載の細胞処理装置。 The cell processing apparatus according to claim 12, wherein the plurality of filter units include a first filter unit that performs filtration by a tangential flow method and a second filter unit that performs separation using centrifugal force.  前記撹拌部は、スタティックミキサを含む、請求項7に記載の細胞処理装置。 The cell processing apparatus according to claim 7, wherein the stirring unit includes a static mixer.  前記第1の流路に接続された第1の培地供給部を更に含む、請求項1から請求項16のいずれか1項に記載の細胞処理装置。 The cell treatment apparatus according to any one of claims 1 to 16, further comprising a first medium supply unit connected to the first flow path.  前記第3の流路に接続された第2の培地供給部を更に含む、請求項4または請求項5に記載の細胞処理装置。 The cell treatment apparatus according to claim 4 or 5, further comprising a second medium supply unit connected to the third flow path.  前記細胞供給部に洗浄液を供給する洗浄液供給部を更に含む、請求項1から請求項18のいずれか1項に記載の細胞処理装置。 The cell treatment apparatus according to any one of claims 1 to 18, further comprising a cleaning liquid supply unit that supplies a cleaning liquid to the cell supply unit.
PCT/JP2017/025323 2016-07-29 2017-07-11 Cell treatment device Ceased WO2018021022A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016-150671 2016-07-29
JP2016150671A JP2019162035A (en) 2016-07-29 2016-07-29 Cell treatment device

Publications (1)

Publication Number Publication Date
WO2018021022A1 true WO2018021022A1 (en) 2018-02-01

Family

ID=61016614

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/025323 Ceased WO2018021022A1 (en) 2016-07-29 2017-07-11 Cell treatment device

Country Status (2)

Country Link
JP (1) JP2019162035A (en)
WO (1) WO2018021022A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019138796A1 (en) * 2018-01-15 2019-07-18 富士フイルム株式会社 Cell culture device and cell culture method
WO2020009017A1 (en) * 2018-07-05 2020-01-09 富士フイルム株式会社 Cell culture device and stirring method

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08114601A (en) * 1994-10-18 1996-05-07 Hitachi Ltd Multi-item inspection and analysis device for liquid samples
WO2009016078A2 (en) * 2007-07-31 2009-02-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for culturing mammalian stem cells
JP2010011792A (en) * 2008-07-03 2010-01-21 Hitachi Plant Technologies Ltd Method for isolating biological cell, and system for culturing the same
WO2011106681A2 (en) * 2010-02-25 2011-09-01 The Johns Hopkins University SMOOTH MUSCLE-LIKE CELLS (SMLCs) DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
JP2013517771A (en) * 2010-01-22 2013-05-20 ロンザ ウォーカーズヴィル,インコーポレーテッド High yield method and apparatus for volume reduction and washing of therapeutic cells using tangential flow filtration
CN103382436A (en) * 2013-06-24 2013-11-06 江苏元洲生物工程有限公司 Continuous perfusion device of fermentation tank
WO2014136581A1 (en) * 2013-03-06 2014-09-12 国立大学法人京都大学 Culture system for pluripotent stem cells and method for subculturing pluripotent stem cells
WO2015003012A2 (en) * 2013-07-01 2015-01-08 Olivier Berteau Distributed perfusion bioreactor system for continuous culture of biological cells
WO2015160863A1 (en) * 2014-04-14 2015-10-22 Sri International Portable nucleic acid analysis systemand high-performance microfluidic electroactive polymer actuators
WO2016113369A1 (en) * 2015-01-16 2016-07-21 General Electric Company Pluripotent stem cell expansion and passage using a rocking platform bioreactor

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08114601A (en) * 1994-10-18 1996-05-07 Hitachi Ltd Multi-item inspection and analysis device for liquid samples
WO2009016078A2 (en) * 2007-07-31 2009-02-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for culturing mammalian stem cells
JP2010011792A (en) * 2008-07-03 2010-01-21 Hitachi Plant Technologies Ltd Method for isolating biological cell, and system for culturing the same
JP2013517771A (en) * 2010-01-22 2013-05-20 ロンザ ウォーカーズヴィル,インコーポレーテッド High yield method and apparatus for volume reduction and washing of therapeutic cells using tangential flow filtration
WO2011106681A2 (en) * 2010-02-25 2011-09-01 The Johns Hopkins University SMOOTH MUSCLE-LIKE CELLS (SMLCs) DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
WO2014136581A1 (en) * 2013-03-06 2014-09-12 国立大学法人京都大学 Culture system for pluripotent stem cells and method for subculturing pluripotent stem cells
CN103382436A (en) * 2013-06-24 2013-11-06 江苏元洲生物工程有限公司 Continuous perfusion device of fermentation tank
WO2015003012A2 (en) * 2013-07-01 2015-01-08 Olivier Berteau Distributed perfusion bioreactor system for continuous culture of biological cells
WO2015160863A1 (en) * 2014-04-14 2015-10-22 Sri International Portable nucleic acid analysis systemand high-performance microfluidic electroactive polymer actuators
WO2016113369A1 (en) * 2015-01-16 2016-07-21 General Electric Company Pluripotent stem cell expansion and passage using a rocking platform bioreactor

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ABECASIS, B. ET AL.: "Expansion of 3D human induced pluripotent stem cell aggregates in bioreactors: Bioprocess intensification and scaling-up approaches", J. BIOTECHNOL., vol. 246, 25 January 2017 (2017-01-25), pages 81 - 93, XP055605055 *
BAPTISTA, R.P. ET AL.: "High Density Continuous Production of Murine Pluripotent Cells in an Acoustic Perfused Bioreactor at Different Oxygen Concentrations", BIOTECHNOL. BIOENG., vol. 110, 2012, pages 648 - 655, XP055605052 *
HASSAN, S. ET AL.: "Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions", REGEN. MED., vol. 10, no. 5, 2015, pages 591 - 609, XP055605049 *
OTSUJI, T.G. ET AL.: "A 3D Sphere Culture System Containing Functional Polymers for Large-Scale Human Pluripotent Stem Cell Production", STEM CELL REPORTS, vol. 2, 2014, pages 734 - 745, XP055171477, DOI: doi:10.1016/j.stemcr.2014.03.012 *
SERRA, M. ET AL.: "Process engineering of human Pluripotent stem cells for clinical application", TRENDS BIOTECHNOL., vol. 30, no. 6, 2012, pages 350 - 359, XP028507545, DOI: doi:10.1016/j.tibtech.2012.03.003 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019138796A1 (en) * 2018-01-15 2019-07-18 富士フイルム株式会社 Cell culture device and cell culture method
WO2020009017A1 (en) * 2018-07-05 2020-01-09 富士フイルム株式会社 Cell culture device and stirring method
JPWO2020009017A1 (en) * 2018-07-05 2021-06-03 富士フイルム株式会社 Cell culture device and stirring method
JP7030980B2 (en) 2018-07-05 2022-03-07 富士フイルム株式会社 Cell culture device and stirring method

Also Published As

Publication number Publication date
JP2019162035A (en) 2019-09-26

Similar Documents

Publication Publication Date Title
CA2753605C (en) Two-step single-tank filtration method with diafiltration
RU2432323C2 (en) Equipment with bioreactor and membrane filter for water treatment
JPWO2018003476A1 (en) Cell suspension membrane separation method and cell culture apparatus
JP2005500156A (en) System and method for collecting permeate through a filter and cleaning the filter in that position
JP2009038998A (en) Cell-separating device
JP2009533214A (en) Microfiltration device using flexible filter module
JPWO2009050783A1 (en) Filtration method and apparatus for waste liquid
WO2018021022A1 (en) Cell treatment device
CN105969651A (en) Microorganism oscillating cleaning and recycling system
JP7030849B2 (en) Cell culture device and cell culture method
JP2018070519A (en) Cell formulation production method and apparatus as well as cell formulation produced by production apparatus
JPH05306978A (en) Microorganism measuring instrument
US20230358777A1 (en) Fluidic network for positive displacement aseptic sampling
CN109354267B (en) A kind of fabric sewage disposal device
CN208617568U (en) A kind of precoating tunic air bearing integrated device
WO2021049117A1 (en) Cell culture device
JP2017064689A (en) Filtration method and apparatus using porous glass membrane with uniform pore distribution
US20230358644A1 (en) Fluidic network for aseptic sampling
US10232104B2 (en) Cell filter separation system
JPH07256283A (en) Cross-flow type membrane separation water treatment apparatus
JP2015188769A (en) Pretreatment device for online measurement in water system, online measurement device equipped with the same, and pretreatment method for online measurement
CN202315717U (en) Ultrafiltration membrane cleaning machine
CN208250040U (en) A kind of flat ceramic film water treatment equipment
KR100805914B1 (en) Precision Filtration System
JP6157851B2 (en) Washing waste liquid treatment apparatus and washing waste liquid treatment method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17834030

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17834030

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP